rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCATTAGGGGTCCGGGGAATGAGCAGTTCTTCGGGCCA	CASSAIRGPGNEQFF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	3	5	2	7	5	7	23	36	46	41	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAIRGPGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGTCGGGCCGGATGGCTTTCTTTGGACAA	CASSPSGRMAFF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	36	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	8	0	11	5	6	23	35	44	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPSGRMAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGAACTAGTTCAGAAGCAGTTCTTCGGGCCA	CASSAELVQKQFF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	8	11	4	6	23	36	45	40	51			01,02			01,02							Vb 1	CASSAELVQKQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCAAATAAGTGGGGGACAGGGTCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	2.4452867098667317E-4		52	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	3	12	2	23	35	56	47	58			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCCCTCACATCCGGGACAGGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSVPHIRDRGPYEQYF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	2	11	2	23	37	58	48	60			01,02										Vb 1	CASSVPHIRDRGPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTCCGACAGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSDRPSTDTQYF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	4	0	3	3	23	32	41	35	44			01,02										Vb 1	CASSDRPSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTGACAGGCCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGQNTGELFF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	4	1	2	3	23	35	43	37	46			01,02										Vb 1	CASSLTGQNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGTCTCAGGGACAGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASLRDSYSNQPQHF	In	VDJ	1	60	6.11321677466683E-4	7.032348804500703E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	5	0	5	3	23	31	43	36	46			01,02										Vb 1	CASLRDSYSNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGGGGACAATTGGGAATGAAAAACTGTTTTTTGGCAGT	CASSGGTIGNEKLFF	In	VDJ	1	92	9.373599054489139E-4	0.0010782934833567744	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	6	5	2	6	23	36	44	38	50			01,02										Vb 1	CASSGGTIGNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCGGTTAGCGGGAGTGACGAGCAGTACTTCGGGCCG	CASSVAVSGSDEQYF	In	VDJ	2	109	0.001110567714064474	0.001277543366150961	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	2	5	4	2	23	39	52	43	54			01,02										Vb 1	CASSVAVSGSDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAAGCGCCCGGGACAGAAACTGGAAACACCATATATTTTGGAGAG	CASSEAPGTETGNTIYF	In	VDJ	2	116	0.001181888576435587	0.0013595874355368026	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	2	8	3	23	36	51	44	54			01,02										Vb 1	CASSEAPGTETGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAGGGGCCTATCACCACGAGCAGTACTTCGGGCCG	CASRGAYHHEQYF	In	VDJ	2	129	0.0013143416065533684	0.0015119549929676513	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	5	0	9	23	-1	39	34	48			01,02										Vb 1	CASRGAYHHEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGGCGGACAGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSVEGGQGSTDTQYF	In	VDJ	3	224	0.0022822675958756164	0.0026254102203469294	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	2	0	5	0	23	39	-1	44	53			01,02										Vb 1	CASSVEGGQGSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCCCGGGGGGGGCTGTGGAGCTGTTTTTTGGAGAA	CASSSPGGAVELFF	In	VDJ	5	294	0.0029954762195867467	0.0034458509142053445	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	0	10	4	5	23	35	47	39	52			01,02										Vb 1	CASSSPGGAVELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCAAGACAGGGGGCGCGAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	1.833965032400049E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	6	0	5	29	-1	54	46	59													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCTTCGAAAGGCGGGGATACTACGAGCAGTACTTCGGGCCG	CASSQAFERRGYYEQYF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	3	10	3	29	45	61	55	64													Vb 16	CASSQAFERRGYYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAATCGGGGGGCCCCTGGGAGCAGTACTTCGGGCCG	CASSQESGGPWEQYF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	1	7	2	7	29	46	55	48	62													Vb 16	CASSQESGGPWEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAAGGGTCAACCCTCGCCATCTCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	43	4.381138688511228E-4		59	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	0	5	3	1	2	17	14	31	37	33	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGCGATTCTTTAATGAAAAACTGTTTTTTGGCAGT	CASSQGRFFNEKLFF	In	VDJ	1	50	5.094347312222358E-4	5.860290670417253E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-04	01	1	9	0	4	0	7	29	-1	48	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGRFFNEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACGGGAGAATCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHGRISYNEQFF	In	VDJ	1	51	5.196234258466805E-4	5.977496483825597E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	2	0	0	3	29	-1	49	43	52													Vb 16	CASSHGRISYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGACCCGCGGGGGACCCGCAGATACGCAGTATTTTGGCCCA	CASSQTRGGPADTQYF	In	VDJ	1	54	5.501895097200147E-4	6.329113924050633E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	4	5	5	29	43	55	48	60													Vb 16	CASSQTRGGPADTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCATCGTGGAGCGGCTCTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	56	5.705668989689041E-4		40	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	6	5	1	6	4	29	36	47	42	51						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTGTTCGGTTTTTGGAGCGGGGGGACCACAGAGCAGTTCTTCGGGCCA	CASSLFGFWSGGTTEQFF	In	VDJ	1	56	5.705668989689041E-4	6.563525550867324E-4	54	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	1	10	14	6	27	40	63	54	69													Vb 16	CASSLFGFWSGGTTEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTCCAGGGGGCAGCCATATATTTTGGAGAG	CASSQFQGAAIYF	In	VDJ	1	75	7.641520968333537E-4	8.790436005625879E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	0	11	3	2	29	44	55	47	57													Vb 16	CASSQFQGAAIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGTTTATTTCTGTGCCAGCAGCCCCGGGACCGACTCAGAGTTACTAGCGGGAGGAAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	79	8.049068753311325E-4		61	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	3	1	5	19	3	10	23	54	42	57													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATCTAAGGAATGAGCAGTTCTTCGGGCCA	CASSHLRNEQFF	In	VDJ	2	98	9.98492073195582E-4	0.0011486169714017816	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	3	5	4	7	4	0	29	43	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSHLRNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGACGGATTGAATTACAGGGGGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	143	0.0014569833312955945		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	0	12	3	28	39	59	51	62													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTTACAGGGGCGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	225	0.002292456290500061		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	4	3	3	29	42	52	45	55													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGGGGGCAGGGCATAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	4	253	0.0025777397399845132		52	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	0	2	0	7	29	-1	53	46	60													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGTTACATTTAGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDRYI*GSNQPQHF	Stop	VDJ	6	391	0.003983779598157884		54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	1	11	0	27	44	-1	55	60													Vb 16	CASSQDRYI*GSNQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGGACAGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	1.833965032400049E-4		44	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	1	1	0	24	36	-1	37	47														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTCTCTAGCAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFSSSTGELFF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	7	4	4	2	24	36	45	40	47						01,02								CASSFSSSTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTAGGCCCGAGACAGGGGTACGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVVGPRQGYGANVLTF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	57	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	2	4	13	3	24	36	57	49	60														CASSVVGPRQGYGANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCTCGGGACTAGCGTACCATGAGCAGTTCTTCGGGCCA	CASSSSGLAYHEQFF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	6	8	5	4	24	36	51	41	55						01,02								CASSSSGLAYHEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTCTAGCGGACACTTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	2.8528344948445205E-4		46	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	5	4	3	6	24	36	46	39	52						01,02								X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSVAVYNEQFF	In	VDJ	1	53	5.400008150955699E-4	6.211908110642288E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	5	3	1	1	24	36	43	37	44						01,02								CASSVAVYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTGGGGCTAGCGGTGTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAVLNTGELFF	In	VDJ	1	66	6.724538452133513E-4	7.735583684950774E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	5	1	6	4	24	36	49	42	53						01,02								CASSLGLAVLNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTCCAAAACGGCGGGCAGGTCATGGGGGACCATATATTTTGGAGAG		Out	VDJ	1	75	7.641520968333537E-4		47	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	10	6	1	10	23	0	24	31	-1	54	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAGGACTCAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSEDSTSTDTQYF	In	VDJ	1	89	9.067938215755797E-4	0.001043131739334271	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	0	2	5	24	36	43	38	48						01,02								CASSEDSTSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCCTTGGGGCTTGGGATACGCAGTATTTTGGCCCA	CASSSLGAWDTQYF	In	VDJ	1	72	7.335860129600196E-4	8.438818565400844E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	7	0	6	5	4	18	31	41	36	45														CASSSLGAWDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGGATCGGGGTTGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSLGSGLSNEKLFF	In	VDJ	1	82	8.354729592044667E-4	9.610876699484294E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	3	3	5	4	18	32	42	37	46														CASSLGSGLSNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCAAGGGGGTGGAGATGGCTACACCTTCGGTTCG	CASSEAQGGGDGYTF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	1	6	3	5	23	40	49	43	54														CASSEAQGGGDGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTCAGGGCCCGGGTACGCAGTATTTTGGCCCA	CASSEAQGPGTQYF	In	VDJ	2	105	0.0010698129355666951	0.0012306610407876231	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	8	1	6	23	40	46	41	52														CASSEAQGPGTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWTRSSYNEQFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	8	0	0	3	26	-1	40	36	43			unresolved			01,02							Vb 20	CAWTRSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTTCGGCCGGTGGGGGTCAGCCCCAGCATTTTGGTGAT	CACSAGGGQPQHF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	6	6	1	6	10	0	26	34	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CACSAGGGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGTTCGCCGGGAGATACGCAGTATTTTGGCCCA	CAWSSSPGDTQYF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	5	7	0	26	38	-1	45	49						01,02							Vb 20	CAWSSSPGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCGGAGGGGAGACGGGCCCCAGCATTTTGGTGAT	CAWRRRGDGPQHF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	0	9	2	7	26	37	45	39	52													Vb 20	CAWRRRGDGPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCCGTACTAGCGGGTCCCTGGATGAGCAGTTCTTCGGGCCA	CAWSFRTSGSLDEQFF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	4	8	6	7	26	38	53	44	60						01,02							Vb 20	CAWSFRTSGSLDEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTGAGGGATAGGCAGTTCTTCGGGCCA	CAWSVLRDRQFF	In	VDJ	1	54	5.501895097200147E-4	6.329113924050633E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	0	12	3	4	26	40	48	43	52			unresolved										Vb 20	CAWSVLRDRQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGACAGCCTGACCGGGGAGCTGTTTTTTGGAGAA	CAWSVDSLTGELFF	In	VDJ	1	63	6.418877613400171E-4	7.383966244725738E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	5	5	0	4	26	-1	46	40	50			unresolved										Vb 20	CAWSVDSLTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCTTTGGACAGGACCCACTTCCTTGGCTACACCTTCGGTTCG	CAWALDRTHFLGYTF	In	VDJ	1	63	6.418877613400171E-4	7.383966244725738E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	7	5	11	26	35	47	40	58			unresolved										Vb 20	CAWALDRTHFLGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCACAGAATGGGACTAGCGGTCTACGAGCAGTACTTCGGGCCG	CAWHRMGLAVYEQYF	In	VDJ	3	192	0.0019562293678933853	0.002250351617440225	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	5	3	8	1	26	35	54	43	55			unresolved			01,02							Vb 20	CAWHRMGLAVYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACCTCCTACGAGCAGTACTTCGGGCCG	CAWSVTSYEQYF	In	VDJ	5	315	0.0032094388067000854	0.003691983122362869	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	0	3	7	0	1	0	26	40	-1	41	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVTSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCTCCCAGGGGGCTCCAAACACTGAAGCTTTCTTTGGACAA	CAWGSQGAPNTEAFF	In	VDJ	7	466	0.004747931694991238	0.00546179090482888	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	0	2	6	4	26	35	49	41	53			unresolved										Vb 20	CAWGSQGAPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGACGGGTAGATACGCAGTATTTTGGCCCA	CASSQGRVDTQYF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	8	4	5	2	1	23	39	45	41	46						01,02								CASSQGRVDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAAGAGGGGGCAAAGTTCTTCGGGCCA	CTSSQEEGAKFF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	36	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	14	2	2	23	40	49	42	51														CTSSQEEGAKFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGCCACAGGGGCAAGCCTACGAGCAGTACTTCGGGCCG	CASSQGPQGQAYEQYF	In	VDJ	1	24	2.4452867098667317E-4	2.8129395218002813E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	2	2	4	4	23	39	50	43	54														CASSQGPQGQAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTGTTGGGACTACCCTACGAAAGACCCAGTACTTCGGGCCA	CASSQVVGTTLRKTQYF	In	VDJ	1	60	6.11321677466683E-4	7.032348804500703E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	9	6	5	9	23	39	51	44	60						01,02								CASSQVVGTTLRKTQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGGTCTAACCTAGGAGTTTGGACTGAAGCTTTCTTTGGACAA	CASRSNLGVWTEAFF	In	VDJ	3	164	0.0016709459184089334	0.0019221753398968588	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	8	5	7	8	23	34	45	41	53						01,02								CASRSNLGVWTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGATCGGGGGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRSGAGANVLTF	In	VDJ	3	189	0.0019256632840200514	0.0022151898734177216	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	4	6	0	4	4	1	23	36	46	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRSGAGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAAGGACAGGGGTCGAGCAGTACTTCGGGCCG	CASSQERTGVEQYF	In	VDJ	4	290	0.002954721441088968	0.0033989685888420064	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	2	6	2	1	23	40	51	42	52														CASSQERTGVEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCGATTAGCGGGCCCCAGACGGACAGATACGCAGTATTTTGGCCCA	CASSRLAGPRRTDTQYF	In	VDJ	5	347	0.0035354770346823165	0.004067041725269573	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	4	3	5	10	23	34	46	39	56						01,02								CASSRLAGPRRTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACCAAGGGACAGGGGGAGAAAAACTGTTTTTTGGCAGT	CASSHQGTGGEKLFF	In	VDJ	7	456	0.0046460447487467905	0.005344585091420534	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	1	8	4	1	23	37	52	41	53														CASSHQGTGGEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGAGGGTCTCCTAACAGATACGCAGTATTTTGGCCCA	CASSLAEGLLTDTQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	11	0	3	2	7	19	35	42	37	49													Vb 5.1	CASSLAEGLLTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTTCCACTAGCGGGGCCCGCACAGATACGCAGTATTTTGGCCCA	CASSFSTSGARTDTQYF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	3	3	1	4	3	19	33	47	37	50													Vb 5.1	CASSFSTSGARTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCCAGGCGGGAGGGCTGGTGAGACCCAGTACTTCGGGCCA	CASSSPGGRAGETQYF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	0	5	6	5	19	32	47	38	52													Vb 5.1	CASSSPGGRAGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTAGACTAGCGGTGAACAATGAGCAGTTCTTCGGGCCA	CASSFRLAVNNEQFF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	5	5	2	3	19	33	44	35	47						01,02							Vb 5.1	CASSFRLAVNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCAAAGGGGGCAGAACATGAAAAACTGTTTTTTGGCAGT	CASSPKGAEHEKLFF	In	VDJ	1	35	3.566043118555651E-4	4.102203469292077E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	0	6	4	5	19	31	42	35	47													Vb 5.1	CASSPKGAEHEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAGACAGGGCGAAATGAAAAACTGTTTTTTGGCAGT	CASSETGRNEKLFF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	3	5	2	3	19	31	40	33	43													Vb 5.1	CASSETGRNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAGGGGCTGCGTGAAAAACTGTTTTTTGGCAGT	CASSPEGLREKLFF	In	VDJ	1	51	5.196234258466805E-4	5.977496483825597E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	0	7	2	6	19	31	39	33	45													Vb 5.1	CASSPEGLREKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGACTTGCGCAAGAGAATGAGCAGTTCTTCGGGCCA	CASSFGLAQENEQFF	In	VDJ	1	60	6.11321677466683E-4	7.032348804500703E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	10	7	1	10	19	33	39	34	49						01,02							Vb 5.1	CASSFGLAQENEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGCAATGGGACAGGGGTGGAACAATGAGCAGTTCTTCGGGCCA	CASAMGQGWNNEQFF	In	VDJ	1	68	6.928312344622407E-4	7.969995311767464E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	2	5	5	4	19	28	43	33	47													Vb 5.1	CASAMGQGWNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCTGAACGGACAGGGGGCTGGAAACACCATATATTTTGGAGAG	CASSLNGQGAGNTIYF	In	VDJ	3	164	0.0016709459184089334	0.0019221753398968588	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	1	2	7	0	19	30	-1	37	47													Vb 5.1	CASSLNGQGAGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGACAGGGGGCGCAGGGCGAGCAGTACTTCGGGCCG	CASRGQGAQGEQYF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	6	0	6	25	-1	48	36	54													Vb 3	CASRGQGAQGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAGGGACGAGGGGCTACGAGCAGTACTTCGGGCCG	CASSLSGTRGYEQYF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	1	0	7	3	2	6	25	41	48	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSGTRGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGTCCGTCAGCCCCAGCATTTTGGTGAT	CASSPVRQPQHF	In	VDJ	1	32	3.260382279822309E-4	3.7505860290670416E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	6	6	2	4	25	37	41	39	45						01,02							Vb 3	CASSPVRQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCCATGAAGGGGGCGCCGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	37	3.769817011044545E-4		49	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	0	6	9	7	25	35	51	44	58													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGGGGACCAATCAGCCCCAGCATTTTGGTGAT	CASSLGGTNQPQHF	In	VDJ	1	39	3.973590903533439E-4	4.571026722925457E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	9	0	3	0	2	25	-1	46	39	48													Vb 3	CASSLGGTNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACTCCGGGGCCTTAGAAGCTTTCTTTGGACAA		Out	VDJ	1	41	4.1773647960223335E-4		40	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	7	0	8	6	4	25	38	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGCGGGACAGGGCTATCAGCCCCAGCATTTTGGTGAT	CASSFAGQGYQPQHF	In	VDJ	1	44	4.483025634755675E-4	5.157055789967183E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	5	3	2	25	39	51	42	53													Vb 3	CASSFAGQGYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSFGPQETQYF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	3	8	0	1	1	1	25	39	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFGPQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGAGCGGGAGCCCTTATTTCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	49	4.99246036597791E-4		55	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	2	0	2	9	25	39	49	41	58													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAGGAGGAAGCCTGACAGATACGCAGTATTTTGGCCCA	CASSPGGSLTDTQYF	In	VDJ	1	55	5.603782043444594E-4	6.446319737458978E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	3	3	7	25	37	45	40	52													Vb 3	CASSPGGSLTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAACAGCAGGGTCCAAGCTTTCTTTGGACAA	CASSNSRVQAFF	In	VDJ	1	56	5.705668989689041E-4	6.563525550867324E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	9	5	3	25	37	47	42	50													Vb 3	CASSNSRVQAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGATCGGGACACAGGGTTGGTACTTCGGGCCA	CASRIGTQGWYF	In	VDJ	1	58	5.909442882177935E-4	6.797937177684013E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	13	4	8	25	36	46	40	54													Vb 3	CASRIGTQGWYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTCTGGGGAAGGGCGATGATTACGAGCAGTACTTCGGGCCG	CASSLFLGKGDDYEQYF	In	VDJ	1	62	6.316990667155724E-4	7.266760431317394E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	1	0	8	4	5	11	25	41	50	46	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLFLGKGDDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGCCAAGGGGGGCTAAACTATGGCTACACCTTCGGTTCG	CASSGQGGLNYGYTF	In	VDJ	1	67	6.82642539837796E-4	7.852789498359119E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	5	1	2	5	4	25	37	48	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSGQGGLNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGGTAGACACTGAAGCTTTCTTTGGACAA	CASSLRVDTEAFF	In	VDJ	1	75	7.641520968333537E-4	8.790436005625879E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	5	3	3	0	3	25	-1	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLRVDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCTCGGGGAGCGGACCCACAGATACGCAGTATTTTGGCCCA	CASGSGPTDTQYF	In	VDJ	2	100	0.0010188694624444715	0.0011720581340834506	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	6	5	2	6	3	25	31	42	37	45						01,02							Vb 3	CASGSGPTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACACCCCGCTCCTACGAGCAGTACTTCGGGCCG	CASRTPRSYEQYF	In	VDJ	2	109	0.001110567714064474	0.001277543366150961	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	6	0	1	5	25	36	40	37	45													Vb 3	CASRTPRSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCCAGGTTTTCTGGCTACACCTTCGGTTCG	CASSFSRFSGYTF	In	VDJ	2	110	0.0011207564086889187	0.0012892639474917957	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	4	7	3	5	25	39	46	42	51													Vb 3	CASSFSRFSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGACAGGGAACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSRQGTGNTEAFF	In	VDJ	2	138	0.001406039858173371	0.0016174402250351617	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	1	1	6	25	37	45	38	51													Vb 3	CASSRQGTGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGATCGCGGCTTCCTACAATGAGCAGTTCTTCGGGCCA	CASRIAASYNEQFF	In	VDJ	2	147	0.0014977381097933734	0.0017229254571026723	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	7	5	1	4	2	25	36	44	40	46						01,02							Vb 3	CASRIAASYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCACTCGGAGGCTAGCGGGGGTCACAGATACGCAGTATTTTGGCCCA	CASITRRLAGVTDTQYF	In	VDJ	3	170	0.0017320780861556017	0.0019924988279418658	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	4	2	2	11	1	25	35	56	46	57													Vb 3	CASITRRLAGVTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGAACATGAACACTGAAGCTTTCTTTGGACAA	CASSFQNMNTEAFF	In	VDJ	4	276	0.002812079716346742	0.0032348804500703233	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	6	0	5	0	25	39	-1	44	47													Vb 3	CASSFQNMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGCGGGACAGGGCCCACAGATACGCAGTATTTTGGCCCA	CAGGTGPTDTQYF	In	VDJ	6	358	0.0036475526755512084	0.004195968120018753	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	0	3	2	3	2	25	31	43	34	45													Vb 3	CAGGTGPTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGACTAGCGGGATTCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	9	597	0.0060826506907934955		50	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	3	0	1	3	25	38	50	39	53													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	20	1306	0.0133064351795248	0.015307079231129865	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	25	37	50	38	59													Vb 3	CASSPSGRASRNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCCTTGGGACCTCACAGATACGCAGTATTTTGGCCCA	CASSPPWDLTDTQYF	In	VDJ	34	2213	0.022547581203896157	0.02593764650726676	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	6	0	7	2	8	2	25	36	49	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPPWDLTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCACACAACTAGCGGCCAACACCGGGGAGCTGTTTTTTGGAGAA	CATQLAANTGELFF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	12	3	5	2	6	2	18	23	37	29	39						01,02								CATQLAANTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCACCCGTCCGGGACTAGCGGGAGTGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CATRPGLAGVGAYNEQFF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	54	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	0	2	2	9	6	18	23	46	32	52														CATRPGLAGVGAYNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCACCGATTCCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATDSLSGANVLTF	In	VDJ	1	90	9.169825162000245E-4	0.0010548523206751054	42	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-06	01	12	2	8	0	4	6	18	23	29	27	35				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATDSLSGANVLTF+TCRBV12-02+TCRBJ02-06	TCRBV12-02*01		TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTGGTTAGCGGGAGGGCCCCTGAGCAGTTCTTCGGGCCA	CASSLVSGRAPEQFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	0	9	3	4	23	37	51	40	55													Vb 14	CASSLVSGRAPEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATTCCCAGGGTGGCTATGGCTACACCTTCGGTTCG	CSVDSQGGYGYTF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	4	4	3	25	36	45	40	48													Vb 4	CSVDSQGGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAGGGGTAGGGCCAGATACGCAGTATTTTGGCCCA	CSGGVGPDTQYF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	7	5	2	4	1	6	25	32	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGGVGPDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAGTCCCGGAGGCGGAAACACCATATATTTTGGAGAG	CSVSPGGGNTIYF	In	VDJ	1	24	2.4452867098667317E-4	2.8129395218002813E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	10	1	4	7	1	25	33	45	40	46													Vb 4	CSVSPGGGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCGGTGGGACAGGGGGTACAATGAGCAGTTCTTCGGGCCA	CSVEDRWDRGYNEQFF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	1	4	5	0	25	39	-1	44	55													Vb 4	CSVEDRWDRGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTCGTTTCTAGAGGGGATACGCAGTATTTTGGCCCA	CSVLVSRGDTQYF	In	VDJ	1	35	3.566043118555651E-4	4.102203469292077E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	0	6	11	0	25	33	-1	44	49													Vb 4	CSVLVSRGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGATTTCGAACAGGCGTAATTTCGACGAGCAGTACTTCGGGCCG	CSVWISNRRNFDEQYF	In	VDJ	1	35	3.566043118555651E-4	4.102203469292077E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	5	10	10	25	34	49	44	59													Vb 4	CSVWISNRRNFDEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGACCCCGTAGCGGGAGGAGGCGAGCAGTACTTCGGGCCG	CSVDPVAGGGEQYF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	1	6	8	3	25	33	51	41	54													Vb 4	CSVDPVAGGGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCTCCTAAGGCTAGCGGGTATCAATGAGCAGTTCTTCGGGCCA	CSVVLLRLAGINEQFF	In	VDJ	1	40	4.0754778497778863E-4	4.6882325363338024E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	4	6	11	3	25	35	54	46	57						01,02							Vb 4	CSVVLLRLAGINEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCCCGATCTCCGCCTACGAGCAGTACTTCGGGCCG	CSVGPISAYEQYF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	4	2	8	2	4	6	25	35	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGPISAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAGGGACGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CSARDGGNQPQHF	In	VDJ	1	44	4.483025634755675E-4	5.157055789967183E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	7	0	7	2	3	4	25	32	40	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSARDGGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACTAAATCTAACTATGGCTACACCTTCGGTTCG	CSVTKSNYGYTF	In	VDJ	1	48	4.890573419733463E-4	5.625879043600563E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	9	0	0	3	25	-1	38	34	41						01,02							Vb 4	CSVTKSNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTCGGTCAGCCATTGGGGCTACACCTTCGGTTCG	CSVGSVSHWGYTF	In	VDJ	1	57	5.807555935933488E-4	6.680731364275668E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	4	4	5	8	7	7	25	35	45	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGSVSHWGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGACTAGCGGGAGGGAATGAGCAGTTCTTCGGGCCA	CSARLAGGNEQFF	In	VDJ	1	68	6.928312344622407E-4	7.969995311767464E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	2	0	7	3	0	25	32	-1	35	49													Vb 4	CSARLAGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGCAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CSVEAGGNTEAFF	In	VDJ	1	94	9.577372946978033E-4	0.0011017346460384435	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	1	2	0	25	36	-1	38	45													Vb 4	CSVEAGGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCACGGGAGGGATACGAGCAGTACTTCGGGCCG	CSVAREGYEQYF	In	VDJ	2	106	0.0010800016301911399	0.0012423816221284576	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	0	4	2	1	25	35	45	37	46													Vb 4	CSVAREGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGCGGGACACCCTAATCAGCCCCAGCATTTTGGTGAT	CSVVAGHPNQPQHF	In	VDJ	2	111	0.0011309451033133635	0.00130098452883263	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	4	0	6	4	4	4	25	35	45	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVAGHPNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGGGACAGGGGGTTTACCTACGAGCAGTACTTCGGGCCG	CSVRDRGFTYEQYF	In	VDJ	2	112	0.0011411337979378082	0.0013127051101734647	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	2	2	4	25	33	46	35	50													Vb 4	CSVRDRGFTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATCGAGGAGGCACAGATACGCAGTATTTTGGCCCA	CSVDRGGTDTQYF	In	VDJ	2	127	0.001293964217304479	0.0014885138302859822	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	2	1	4	0	25	36	-1	40	44													Vb 4	CSVDRGGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTCAGCGGGAATAGCGGCACAGATACGCAGTATTTTGGCCCA	CSVEVSGNSGTDTQYF	In	VDJ	2	133	0.0013550963850511473	0.0015588373183309892	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	6	3	1	2	6	25	38	47	40	53													Vb 4	CSVEVSGNSGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGGGAACTCTCCTACGAGCAGTACTTCGGGCCG	CSVGGELSYEQYF	In	VDJ	2	140	0.0014264172474222603	0.0016408813877168307	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	1	0	0	4	25	-1	41	35	45													Vb 4	CSVGGELSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGACCTGCACTAGCATACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	155	0.001579247666788931		52	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	3	7	5	8	9	25	34	48	42	57						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGGGGGACTTGCTAATGAAAAACTGTTTTTTGGCAGT	CSVRGGLANEKLFF	In	VDJ	3	176	0.00179321025390227	0.002062822315986873	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	9	0	3	2	5	25	33	42	35	47													Vb 4	CSVRGGLANEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGACAGTTCTTCTGGAAACACCATATATTTTGGAGAG	CSVEDSSSGNTIYF	In	VDJ	4	261	0.002659249296980071	0.003059071729957806	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	5	1	0	4	25	-1	42	36	46													Vb 4	CSVEDSSSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTCACCGGGACACGGCGAGCAGTACTTCGGGCCG	CASSSPGHGEQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	6	2	3	22	37	45	39	48		TCRBV07-01,TCRBV07-02												CASSSPGHGEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGCAGGTACCTACAATGAGCAGTTCTTCGGGCCA	CASSEAGTYNEQFF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	4	2	1	2	23	38	43	39	45		TCRBV10-01,TCRBV10-02												CASSEAGTYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGTAATTGGGACAGTCAAGAGACCCAGTACTTCGGGCCA	CASNWDSQETQYF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	0	5	2	5	1	26	34	46	39	47		TCRBV06-07,TCRBV06-09												CASNWDSQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCTCGTCACTAGCGGGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSSLAGTTGELFF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	45	TCRBV12	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	3	3	4	5	2	22	31	46	36	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSLAGTTGELFF+TCRBV12-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCGACTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRLSGANVLTF	In	VDJ	1	26	2.649060602355626E-4	3.0473511486169713E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	2	10	0	2	0	26	37	-1	39	43		TCRBV06-07,TCRBV06-08				01,02								CASSRLSGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGCCGGGACCCTGCCGAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	27	2.750947548600073E-4		47	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	5	0	7	6	4	9	26	38	47	42	56		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCCGTCTAAACATATTTCGAGGAGATACGCAGTATTTTGGCCCA	CASRLNIFRGDTQYF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	11	1	5	16	0	26	35	-1	51	55		TCRBV06-08,TCRBV06-09												CASRLNIFRGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCCTCACCCCCGCCGGGACAAGCACAGATACGCAGTATTTTGGCCCA	CASTLTPAGTSTDTQYF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	6	0	14	0	26	36	-1	50	56		TCRBV06-07,TCRBV06-08												CASTLTPAGTSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGACTAGCGGGAAACACCCTTGGGGAATGAGCAGTTCTTCGGGCCA	CASSED*RETPLGNEQFF	Stop	VDJ	1	40	4.0754778497778863E-4		54	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	2	3	7	0	13	23	-1	49	38	62		TCRBV10-01,TCRBV10-02												CASSED*RETPLGNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTTGGGGGACGCGGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFGGRGGANVLTF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	48	TCRBV07	unresolved					TCRBJ02	TCRBJ02-06	01	3	0	7	3	3	4	19	33	41	36	45		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGRGGANVLTF+TCRBV07-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACAGAGACTAGCGGGGACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	4.381138688511228E-4		44	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	2	3	5	4	2	26	36	51	40	53		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCCGGTTTCGGGGTTTACGAGCAGTACTTCGGGCCG	CASSPGFGVYEQYF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	42	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	4	8	2	19	31	44	39	46		TCRBV11-01,TCRBV11-03												CASSPGFGVYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCATCTAAATCCCGCGACAGCCATCGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	48	4.890573419733463E-4		52	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	2	5	3	12	6	28	38	55	50	61		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTGAACCGGGCAGGTACTGAAAAACTGTTTTTTGGCAGT	CASSLNRAGTEKLFF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	45	TCRBV07	unresolved					TCRBJ01	TCRBJ01-04	01	2	4	4	7	8	3	19	33	45	41	48		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNRAGTEKLFF+TCRBV07-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCTAAACCTTAGCGGGACTGTCGTTACAATGAACAGTTCTTCGGGCCA		Out	VDJ	1	58	5.909442882177935E-4		52	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	5	3	13	9	16	23	33	50	42	66		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGTTCCGGGTCGCTCCTACGAGCAGTACTTCGGGCCG	CASSLVPGRSYEQYF	In	VDJ	2	110	0.0011207564086889187	0.0012892639474917957	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	0	3	3	18	34	41	37	44		TCRBV11-01,TCRBV11-03				01,02								CASSLVPGRSYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTGGGTCGCGGGAGGGGGAAACATTCAGTACTTCGGCGCC	CASSWVAGGGNIQYF	In	VDJ	3	181	0.0018441537270244936	0.0021214252226910454	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	7	0	6	5	2	18	31	45	36	47		TCRBV11-01,TCRBV11-03												CASSWVAGGGNIQYF+TCRBV11-X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGCCAGGAACCCTTGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASRPGTLGPGELFF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	4	6	2	11	23	34	40	36	51													Vb 22	CASRPGTLGPGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATTACGCTAGCGGGAGTATCAACGAGCAGTACTTCGGGCCG	CASSDYASGSINEQYF	In	VDJ	1	79	8.049068753311325E-4	9.25925925925926E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	5	5	5	23	37	52	42	57													Vb 22	CASSDYASGSINEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCAGGGGGATGGAGATCTCCCCTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	3.3622692260667564E-4		56	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	1	2	0	16	25	-1	48	42	64			01,02											X+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACTGGGGGATTACTAATGAAAAACTGTTTTTTGGCAGT	CASSYWGITNEKLFF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	45	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-04	01	1	6	1	2	0	3	28	-1	49	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWGITNEKLFF+TCRBV06-04+TCRBJ01-04	TCRBV06-04		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAAGACAGGGGTGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSKTGVYTGELFF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	3	2	3	26	38	48	40	51														CASSKTGVYTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCCGCCACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	48	4.890573419733463E-4		44	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	0	4	6	0	3	0	26	43	-1	46	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCGCAGGGTGGACCGGGGAGCTGTTTTTTGGAGAA	CAAGWTGELFF	In	VDJ	1	62	6.316990667155724E-4	7.266760431317394E-4	33	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	4	3	5	1	3	26	32	38	33	41														CAAGWTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGAGGGACAGGGGGGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	90	9.169825162000245E-4		47	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	1	7	2	2	26	43	56	45	58														X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATAGGAGGTTACGAGCAGTACTTCGGGCCG	CASIGGYEQYF	In	VDJ	1	96	9.781146839466927E-4	0.0011251758087201125	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	10	1	4	2	1	26	36	43	38	44														CASIGGYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCCGGGCGGAGGGTCGACTATGGCTACACCTTCGGTTCG	CASSQSGRRVDYGYTF	In	VDJ	1	28	2.8528344948445205E-4	3.281762775433662E-4	48	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	0	3	5	3	29	46	57	51	60			01,02											CASSQSGRRVDYGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD02-01*02	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATACCGGGATCTGGGGACTGAAGCTTTCTTTGGACAA	CASSQYRDLGTEAFF	In	VDJ	3	186	0.0018950972001467172	0.002180028129395218	45	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	8	3	5	2	7	29	45	52	47	59			01,02											CASSQYRDLGTEAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAACAGGCCGGAATGAGCAGTTCTTCGGGCCA	CASSLTGRNEQFF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	4	7	2	4	22	35	42	37	46														CASSLTGRNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCATTATCCGGGACGGATCCTACGAGCAGTACTTCGGGCCG	CAIIRDGSYEQYF	In	VDJ	1	24	2.4452867098667317E-4	2.8129395218002813E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-07	01	10	0	7	1	6	3	22	29	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIIRDGSYEQYF+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACCCCGGATCCACCGGGTCCAATGAGCAGTTCTTCGGGCCA	CASSDPGSTGSNEQFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	4	6	12	2	23	37	53	49	55						01,02							Vb 12	CASSDPGSTGSNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCCAGGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGGSNQPQHF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	0	1	2	0	23	34	-1	36	44													Vb 12	CASSPGGSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGCTTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	54	5.501895097200147E-4		40	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	2	0	2	23	-1	43	40	45													Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAACCCGGGGGGCAGTCGAATGAGCAGTTCTTCGGGCCA	CASKPGGQSNEQFF	In	VDJ	1	73	7.437747075844643E-4	8.556024378809189E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	1	7	4	6	23	33	44	37	50													Vb 12	CASKPGGQSNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAACCACAGGGGTCAGGCGGCTACACCTTCGGTTCG	CASSEPQGSGGYTF	In	VDJ	1	74	7.53963402208909E-4	8.673230192217535E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	2	8	3	6	23	37	47	40	53													Vb 12	CASSEPQGSGGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGTGAGCGGGAGAAGACCCAGTACTTCGGGCCA	CASGEREKTQYF	In	VDJ	1	82	8.354729592044667E-4	9.610876699484294E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	2	6	0	1	23	-1	44	38	45													Vb 12	CASGEREKTQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGGGAGGACTAGCGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	119	0.0012124546603089212		37	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	1	4	7	3	0	23	31	-1	34	45						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCTCCGGGACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	244	0.0024860414883645108		41	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	4	0	23	35	-1	39	48													Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGACTAGCGGGATTCGGGATACGCAGTATTTTGGCCCA	CAISESTSGIRDTQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	2	3	6	0	5	23	-1	51	40	56													Vb 12	CAISESTSGIRDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCGCAAGCCCGACGGCTTCACAGATACGCAGTATTTTGGCCCA	CASRKPDGFTDTQYF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	45	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-03	01	10	2	7	2	11	5	24	31	45	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRKPDGFTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCGGGGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASRGGQETQYF	In	VDJ	1	36	3.667930064800098E-4	4.219409282700422E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-05	01	10	7	0	1	3	2	24	31	39	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRGGQETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGCGGATGGGGCCAACGTCCTGACTTTCGGGGCC	CAISEADGANVLTF	In	VDJ	1	48	4.890573419733463E-4	5.625879043600563E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	7	5	3	0	1	23	-1	42	38	43						01,02							Vb 12	CAISEADGANVLTF+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01	TCRBD02-01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTGGGGCTGATACGCAGTATTTTGGCCCA	CAISESGADTQYF	In	VDJ	4	239	0.002435098015242287	0.0028012189404594467	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	7	0	6	1	1	23	40	46	41	47													Vb 12	CAISESGADTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACCAGGACTAGCGGGAGCGTACGAGCAGTACTTCGGGCCG	CASKPGLAGAYEQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	2	4	5	2	27	37	55	42	57			01,02										Vb 17	CASKPGLAGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGTTTGGTGCCAAAAGAMCCGACAGCTTTCTATCTCTGTGCCAGTAGACCCGGGACAGGGGTCGACTATGGCTACACCTTCGGTTCG	CASRPGTGVDYGYTF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	3	4	3	36	47	61	51	64			01,02										Vb 17	CASRPGTGVDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCGACAGGCACAACGTCCTGACTTTCGGGGCC	CASRPDRHNVLTF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	4	9	4	2	27	38	48	42	50			01,02										Vb 17	CASRPDRHNVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGACCCGGGACAGGGGTCGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	1.935851978644496E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	24	0	2	3	21	3	37	30	61	51	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTACTCCAGCCTGGGCGGGGGGCTACACCTTCGGTTCG	CASTPTPAWAGGYTF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	7	3	8	17	0	27	37	-1	54	60			01,02										Vb 17	CASTPTPAWAGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGACAGGAATACCGGGGAGCTGTTTTTTGGAGAA	CASSRDRNTGELFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	5	0	3	27	-1	48	40	51			01,02										Vb 17	CASSRDRNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACTAGCCGTAAGCAATGAGCAGTTCTTCGGGCCA	CASSIGLAVSNEQFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	7	6	1	6	27	41	50	42	56			01,02			01,02							Vb 17	CASSIGLAVSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCGCGGGCACGGGAGGTGGCTACACCTTCGGTTCG	CASTPAGTGGGYTF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	8	1	7	12	0	27	37	-1	49	56			01,02										Vb 17	CASTPAGTGGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTCTAGGGGCTCCGGAGAGCAGTTCTTCGGGCCA	CASSFSRGSGEQFF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	10	6	7	27	39	50	45	57			01,02										Vb 17	CASSFSRGSGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAGACCCGGGACAGGGGTCGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	2.8528344948445205E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	25	0	2	3	22	3	37	29	61	51	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGAGTCAGGGACACCACCTACGAGCAGTACTTCGGGCCG	CATRVRDTTYEQYF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	6	2	9	3	27	34	49	43	52			01,02										Vb 17	CATRVRDTTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGGGTTTGAGAACACTGAAGCTTTCTTTGGACAA	CASSMRGFENTEAFF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	1	1	1	5	27	41	48	42	53			01,02										Vb 17	CASSMRGFENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCGGGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSISGSSYEQYF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	8	0	0	3	2	27	41	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISGSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTCCGGGACTAGCCTACGAGCAGTACTTCGGGCCG	CASSTPGLAYEQYF	In	VDJ	1	32	3.260382279822309E-4	3.7505860290670416E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	8	2	4	0	27	40	-1	44	52			01,02			01,02							Vb 17	CASSTPGLAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCTCTAGCGGGAGATACGCAGTATTTTGGCCCA	CASSISLAGDTQYF	In	VDJ	1	32	3.260382279822309E-4	3.7505860290670416E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	4	5	4	0	27	41	-1	45	53			01,02			01,02							Vb 17	CASSISLAGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTTGGGGAATCTGGCTACACCTTCGGTTCG	CASSMVGESGYTF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	0	8	7	5	3	27	41	50	46	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMVGESGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGGGGGGGAATTCTATGGCTACACCTTCGGTTCG	CASSIVGGEFYGYTF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	9	0	4	2	4	27	43	52	45	56			01,02										Vb 17	CASSIVGGEFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGACCTGTTAACTATGGCTACACCTTCGGTTCG	CASSPGPVNYGYTF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	1	7	1	3	4	27	39	46	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPGPVNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACGGACTAGCGGGAGTCTCGAGCAGTACTTCGGGCCG	CASSGRTSGSLEQYF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	2	6	4	3	27	39	56	43	59			01,02										Vb 17	CASSGRTSGSLEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCAGGTAGGGCGCCCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	3.769817011044545E-4		49	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	4	4	0	2	11	27	39	45	41	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATCTCCCCCGGGCAGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CAISPGQGSNQPQHF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	3	0	11	0	27	34	-1	45	50			01,02										Vb 17	CAISPGQGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAATCTGACAGGAACAATCAGCCCCAGCATTTTGGTGAT	CASKSDRNNQPQHF	In	VDJ	1	39	3.973590903533439E-4	4.571026722925457E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	4	3	5	2	27	37	48	42	50			01,02										Vb 17	CASKSDRNNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTTGGGCGGGAGGGCCCGGGAGACCCAGTACTTCGGGCCA	CASSMLGGRARETQYF	In	VDJ	1	39	3.973590903533439E-4	4.571026722925457E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	0	5	5	5	27	41	55	46	60			01,02										Vb 17	CASSMLGGRARETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCCGACGGGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFRRASGANVLTF	In	VDJ	1	39	3.973590903533439E-4	4.571026722925457E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	5	8	0	0	7	0	27	39	-1	46	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFRRASGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCTCTAGTATCACTAGCGGATACACCGGGGAGCTGTTTTTTGGAGAA	CATSSITSGYTGELFF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	3	5	3	11	2	27	34	53	45	55			01,02			01,02							Vb 17	CATSSITSGYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTACCAACGCAGGACAGGTTGGCGACAGCCCCAGCATTTTGGTGAT	CASSTYQRRTGWRQPQHF	In	VDJ	1	43	4.381138688511228E-4	5.039849976558838E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	4	7	12	7	27	40	59	52	66			01,02										Vb 17	CASSTYQRRTGWRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTTTTTGGGGGGAACTGAAGCTTTCTTTGGACAA	CASTFLGGTEAFF	In	VDJ	1	44	4.483025634755675E-4	5.157055789967183E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	1	5	7	1	27	37	50	44	51			01,02										Vb 17	CASTFLGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCAACAGGGGGTTCGGAACGAGCAGTACTTCGGGCCG	CASSQQGVRNEQYF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	5	3	6	27	38	49	41	55			01,02										Vb 17	CASSQQGVRNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCATACCGGGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CATIPGGSYNEQFF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	8	1	1	6	1	27	34	47	40	48			01,02										Vb 17	CATIPGGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCAGGGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSGQGGTNEKLFF	In	VDJ	1	48	4.890573419733463E-4	5.625879043600563E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	1	1	3	1	27	39	49	42	50			01,02										Vb 17	CASSGQGGTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGAGGATACACAGATACGCAGTATTTTGGCCCA	CASSIGGGYTDTQYF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	1	2	1	3	27	43	50	44	53			01,02										Vb 17	CASSIGGGYTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAATCAACCCTACGAGCAGTACTTCGGGCCG	CASSMNQPYEQYF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	2	8	2	0	6	27	-1	43	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMNQPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGGCTATTACGAGCGGGAGAGGGGAACATTCAGTACTTCGGCGCC	CASRGLLRAGEGNIQYF	In	VDJ	1	50	5.094347312222358E-4	5.860290670417253E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	6	2	7	12	5	27	38	58	50	63			01,02										Vb 17	CASRGLLRAGEGNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCTGTGCCAGTAGTATAGATACATTTTTAGAGACTAGCGGGGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIDTFLETSGGPNTGELFF	In	VDJ	1	53	5.400008150955699E-4	6.211908110642288E-4	66	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	2	1	0	12	1	2	19	44	31	45			01,02										Vb 17	CASSIDTFLETSGGPNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAAACCCTATGGGGACTGAAGCTTTCTTTGGACAA	CASSIANPMGTEAFF	In	VDJ	1	55	5.603782043444594E-4	6.446319737458978E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	6	2	5	10	0	27	43	-1	53	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIANPMGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCATCAACAGGGGTCGATGAGCAGTTCTTCGGGCCA	CASTGVDEQFF	In	VDJ	1	57	5.807555935933488E-4	6.680731364275668E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	3	2	8	4	3	27	32	43	36	46			01,02										Vb 17	CASTGVDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGGGCGGATGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIVGRMSSYNEQFF	In	VDJ	1	59	6.011329828422382E-4	6.915142991092358E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	7	0	0	1	7	27	43	49	44	56			01,02										Vb 17	CASSIVGRMSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGAGCGGGGATCGAAGCTTTCTTTGGACAA	CASSIRAGIEAFF	In	VDJ	1	62	6.316990667155724E-4	7.266760431317394E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	6	3	8	3	3	27	41	51	44	54			01,02										Vb 17	CASSIRAGIEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCATGGGCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSTPMGGGYNEQFF	In	VDJ	1	64	6.520764559644618E-4	7.501172058134083E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	1	4	9	0	27	40	-1	49	57			01,02										Vb 17	CASSTPMGGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGGGGGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSIWGLYNEQFF	In	VDJ	1	66	6.724538452133513E-4	7.735583684950774E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	6	0	4	2	2	27	41	49	43	51			01,02										Vb 17	CASSIWGLYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGGAGGGAAATGGAACGGGGAGCTGTTTTTTGGAGAA	CASSIGGGKWNGELFF	In	VDJ	1	67	6.82642539837796E-4	7.852789498359119E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	10	0	7	2	8	27	43	51	45	59			01,02										Vb 17	CASSIGGGKWNGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACTGGGGAGTTGGACAGGTGGCTTTCTTTGGACAA	CASSNWGVGQVAFF	In	VDJ	1	72	7.335860129600196E-4	8.438818565400844E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	4	11	11	2	27	40	58	51	60			01,02										Vb 17	CASSNWGVGQVAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGGTAGGGGTGAACATTCAGTACTTCGGCGCC	CASSAVGVNIQYF	In	VDJ	1	73	7.437747075844643E-4	8.556024378809189E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	5	2	7	5	2	27	39	49	44	51			01,02										Vb 17	CASSAVGVNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGACCGGGACAGGCTTCTCCTACGAGCAGTACTTCGGGCCG	CASSVTGTGFSYEQYF	In	VDJ	1	74	7.53963402208909E-4	8.673230192217535E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	0	6	3	27	39	53	45	56			01,02										Vb 17	CASSVTGTGFSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTTCGGGGTCCAGGGCATCCGGGAACAATGAGCAGTTCTTCGGGCCA	CASSSSGSRASGNNEQFF	In	VDJ	1	76	7.743407914577984E-4	8.907641819034224E-4	54	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	4	3	5	10	9	27	40	55	50	64			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSSGSRASGNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGACTCAGCACAGATACGCAGTATTTTGGCCCA	CASSIGGLSTDTQYF	In	VDJ	1	76	7.743407914577984E-4	8.907641819034224E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	10	0	2	1	27	43	50	45	51			01,02			01,02							Vb 17	CASSIGGLSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSPGGTDTQYF	In	VDJ	1	81	8.25284264580022E-4	9.493670886075949E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	3	2	0	27	39	-1	41	48			01,02										Vb 17	CASSPGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGGGGACTAGCGGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	86	8.762277377022456E-4		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	5	7	3	0	27	38	-1	41	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGCGGTTATACGCAGTATTTTGGCCCA	CASSTGGYTQYF	In	VDJ	1	88	8.96605126951135E-4	0.0010314111579934366	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	7	3	2	27	40	47	43	49			01,02			01,02							Vb 17	CASSTGGYTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGCTCCACAGGGGATAACTATGGCTACACCTTCGGTTCG	CASRSTGDNYGYTF	In	VDJ	1	91	9.271712108244692E-4	0.00106657290201594	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	2	1	6	1	27	36	49	42	50			01,02										Vb 17	CASRSTGDNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGGGGTCTAGAAGCTTTCTTTGGACAA	CASTRGLEAFF	In	VDJ	1	96	9.781146839466927E-4	0.0011251758087201125	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	8	2	4	27	37	44	39	48			01,02										Vb 17	CASTRGLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCAGGTCTACAACTGTTTTTTGGCAGT	CASSISGLQLFF	In	VDJ	1	96	9.781146839466927E-4	0.0011251758087201125	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	4	12	2	5	27	41	47	43	52			01,02										Vb 17	CASSISGLQLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCGGGAGGGTGGACTGAAGCTTTCTTTGGACAA	CASRPGGWTEAFF	In	VDJ	2	99	0.0010086807678200268	0.001160337552742616	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	0	5	2	3	27	38	48	40	51			01,02										Vb 17	CASRPGGWTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGAGGGAACCAGGCCTTCACCGGGGAGCTGTTTTTTGGAGAA	CASGGNQAFTGELFF	In	VDJ	2	101	0.0010290581570689163	0.001183778715424285	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	10	0	4	0	11	27	-1	42	36	53			01,02										Vb 17	CASGGNQAFTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCTGGACTAGCGGGATACACAGATACGCAGTATTTTGGCCCA	CASSAGLAGYTDTQYF	In	VDJ	2	106	0.0010800016301911399	0.0012423816221284576	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	3	2	3	2	27	39	54	42	56			01,02										Vb 17	CASSAGLAGYTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGAGGGCGTGGTTGGCCGGGGAGCTGTTTTTTGGAGAA	CASMRAWLAGELFF	In	VDJ	2	123	0.0012532094388067	0.0014416315049226441	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	11	0	6	1	9	27	37	43	38	52			01,02										Vb 17	CASMRAWLAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGCATAGCGGGAGTGTCTTCGAGCAGTACTTCGGGCCG	CASSSHSGSVFEQYF	In	VDJ	2	124	0.0012633981334311448	0.0014533520862634788	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	2	6	5	6	27	39	53	44	59			01,02										Vb 17	CASSSHSGSVFEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCGGTACGAGCAGTACTTCGGGCCG	CASSLRYEQYF	In	VDJ	2	128	0.0013041529119289237	0.0015002344116268166	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	5	4	3	0	27	39	-1	42	45			01,02			01,02							Vb 17	CASSLRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAGGGTAAATCAGCCCCAGCATTTTGGTGAT	CASRRVNQPQHF	In	VDJ	2	132	0.0013449076904267026	0.0015471167369901547	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	11	0	4	0	2	27	-1	43	38	45			01,02										Vb 17	CASRRVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCGACTAGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSRLAANTGELFF	In	VDJ	2	147	0.0014977381097933734	0.0017229254571026723	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	5	0	4	0	27	39	-1	43	52			01,02			01,02							Vb 17	CASSSRLAANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCAAGGGGGCCTGGGACTTCTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSKGAWDFFSNQPQHF	In	VDJ	2	153	0.0015588702775400415	0.0017932489451476794	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	0	0	4	12	24	36	47	40	59			01,02										Vb 17	CASSSKGAWDFFSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATGTCCAGGTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIMSRLNTGELFF	In	VDJ	3	189	0.0019256632840200514	0.0022151898734177216	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	4	1	6	2	27	41	51	47	53			01,02										Vb 17	CASSIMSRLNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTACAGGGTAGGAACACTGAAGCTTTCTTTGGACAA	CASSLQGRNTEAFF	In	VDJ	3	222	0.002261890206626727	0.00260196905766526	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	1	2	3	27	39	47	41	50			01,02										Vb 17	CASSLQGRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGGGACAGAAAAGTACGAGCAGTACTTCGGGCCG	CASIGTEKYEQYF	In	VDJ	4	265	0.00270000407547785	0.003105954055321144	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	4	2	5	27	37	46	39	51			01,02										Vb 17	CASIGTEKYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSIAPSTDTQYF	In	VDJ	4	284	0.0028935892733422995	0.0033286451007969995	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	10	0	3	0	27	43	-1	46	48			01,02			01,02							Vb 17	CASSIAPSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGCAACCCGGGACGGACTTACGAGCAGTACTTCGGGCCG	CASSSNPGRTYEQYF	In	VDJ	5	296	0.003015853608835636	0.003469292076887014	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	6	0	7	4	9	5	27	38	52	47	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSNPGRTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCCGGGACAGGGGTCGACTATGGCTACACCTTCGGTTCG	CASRPGTGVDYGYTF	In	VDJ	79	5110	0.0520642295309125	0.05989217065166432	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	3	4	3	27	38	52	42	55			01,02										Vb 17	CASRPGTGVDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCACATACCTCTCAGTACCTCTGTGCCACCTAAGACCGAGGATGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	2.547173656111179E-4		41	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	11	1	2	9	4	23	30	43	39	47													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTCGGGGCGCGGGAGCAGTACTTCGGGCCG	CASSEFGAREQYF	In	VDJ	1	39	3.973590903533439E-4	4.571026722925457E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	1	7	0	7	2	4	23	39	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEFGAREQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCTTCGGGTCCGGAAACACCATATATTTTGGAGAG	CASTFGSGNTIYF	In	VDJ	5	341	0.003474344866935648	0.003996718237224566	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	7	8	4	4	4	3	23	33	41	37	44						01,02							Vb 11	CASTFGSGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD02-01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGCTTGTGGCGAAGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CPGSLWRSEQSRANVLTF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	54	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	6	6	5	9	9	25	37	50	46	59						01,02								CPGSLWRSEQSRANVLTF+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01	TCRBD02-01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGGACTAGCGAATACTACGAGCAGTACTTCGGGCCG	XASSQGTSEYYEQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	6	3	0	4	22	-1	47	38	51						01,02							Vb 7.1	XASSQGTSEYYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGAAATCCGTGGGGGAGCAGTTCTTCGGGCCA	CASSQKSVGEQFF	In	VDJ	1	26	2.649060602355626E-4	3.0473511486169713E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-01	01	3	6	2	10	9	0	23	37	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQKSVGEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGTTTAAGAAGCGGGAGTGTCCCAGATACGCAGTATTTTGGCCCA	CASSRLRSGSVPDTQYF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	2	4	8	5	23	36	52	44	57													Vb 7.1	CASSRLRSGSVPDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAAAACCGGGACAAACCACAGATACGCAGTATTTTGGCCCA	CASSQKPGQTTDTQYF	In	VDJ	1	56	5.705668989689041E-4	6.563525550867324E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	6	2	5	3	23	38	49	43	52													Vb 7.1	CASSQKPGQTTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACTCTAGGGTAAAAACCGGGGAGCTGTTTTTTGGAGAA	CASSQDSRVKTGELFF	In	VDJ	1	63	6.418877613400171E-4	7.383966244725738E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-02	01	0	5	3	5	4	5	23	40	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDSRVKTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGTTGGGGGCGACAGCTTTCTTTGGACAA	CASSESLGATAFF	In	VDJ	1	59	6.011329828422382E-4	6.915142991092358E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	10	3	3	26	43	52	46	55			01,02										Vb 12	CASSESLGATAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTAACAGGGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	39	3.973590903533439E-4		41	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	3	4	1	0	22	37	-1	38	44														X+TCRBV12-01+TCRBJ01-04	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCTGACCGGGCCATAAAGACTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	4.381138688511228E-4		49	TCRBV12	TCRBV12-01	01				TCRBJ01	TCRBJ01-05	01	8	8	0	0	5	9	22	31	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-01+TCRBJ01-05	TCRBV12-01*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGGCCGACACAGATACGCAGTATTTTGGCCCA	CSARRADTDTQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	0	2	0	4	26	-1	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSARRADTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGCGGGACCGGGGGAGCAGTACTTCGGGCCG	CASSLAAGPGEQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	3	7	1	6	18	35	42	36	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAAGPGEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
RRGACWCGGCMCTGTATCTCTGYGCCAGCAGCGGGAGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSGRGTGELFF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	0	5	0	2	20	-1	39	31	41	TCRBV05,TCRBV23													CASSGRGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAGAGACCTAGCACAGATACGCAGTATTTTGGCCCA	CASSERPSTDTQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	5	2	7	0	4	2	24	36	43	40	45	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERPSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTCCGACACAGTACTATGGCTACACCTTCGGTTCG	CASSPTQYYGYTF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	6	3	3	4	23	34	41	37	45	TCRBV09,TCRBV12													CASSPTQYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGGTTGGGGAGGTGAAAAACTGTTTTTTGGCAGT	CASGWGGEKLFF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	9	1	7	5	0	23	32	-1	37	43	TCRBV02,TCRBV09													CASGWGGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCGACGCAGGCCGGGTGGCACTGAAGCTTTCTTTGGACAA	CASSQVRRRPGGTEAFF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	51	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	4	4	4	7	8	26	42	53	49	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVRRRPGGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAGGGGCGCAACGAGGGCCGAGAGACCCAGTACTTCGGGCCA	CSAEGRNEGRETQYF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	0	4	0	15	26	-1	40	34	55		TCRBV20-01,TCRBV20-or09_02												CSAEGRNEGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAATCGTTAGCCGGAAACACCATATATTTTGGAGAG	CASSESLAGNTIYF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	7	4	7	1	22	34	45	41	46		TCRBV12-03,TCRBV12-04				01,02								CASSESLAGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAAGCAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEAGDTGELFF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	3	5	0	24	35	-1	40	46	TCRBV02,TCRBV21													CASSEAGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCTCTGCCTTTGGACTAGCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSSAFGLAAGELFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	5	6	10	0	26	37	-1	47	57		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSSAFGLAAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCACCCCCGGGAGAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	2.0377389248889431E-4		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	8	2	2	7	2	26	40	53	47	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTTTAGGGCTAGCGGGAGAGCAGTTCTTCGGGCCA	CSARALGLAGEQFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	3	10	8	0	26	39	-1	47	56		TCRBV20-01,TCRBV20-or09_02												CSARALGLAGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACAGGGTAGATACGCAGTATTTTGGCCCA	CSAHRVDTQYF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	5	1	1	26	35	42	36	43		TCRBV20-01,TCRBV20-or09_02												CSAHRVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGGAGGAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CATSVGGGAGELFF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	6	1	5	24	37	44	38	49		TCRBV24-01,TCRBV24-or09_02												CATSVGGGAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGTAAGCGGGCTACAAGAGACCCAGTACTTCGGGCCA	CASSVSGLQETQYF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	4	2	3	3	19	31	40	34	43	TCRBV07,TCRBV11					01,02								CASSVSGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGTGTGGCGGGATCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	2.0377389248889431E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	7	3	1	4	1	22	38	48	42	49	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCGGACAGGGGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	21	2.1396258711333903E-4		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	1	7	3	0	26	37	-1	40	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGAGGTAGGGGGCAGGTACGAGCAGTACTTCGGGCCG	CASSEVGGRYEQYF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	0	4	6	3	22	33	46	39	49		TCRBV12-03,TCRBV12-04												CASSEVGGRYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTTGGCATGAGGAAGACCGGGGAGCTGTTTTTTGGAGAA	CASSVGMRKTGELFF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	1	5	9	3	22	33	46	42	49	TCRBV12,TCRBV21													CASSVGMRKTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAAGCCAGAAAAATGAAAAACTGTTTTTTGGCAGT	CASSLSQKNEKLFF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	2	4	5	5	3	3	22	37	43	40	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSQKNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGTCCGACTAGCGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLVRLAGSTDTQYF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	4	0	3	1	22	38	51	41	52		TCRBV12-03,TCRBV12-04				01,02								CASSLVRLAGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGGACAGGCATCTACGAGCAGTACTTCGGGCCG	CASSLGTGIYEQYF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	3	3	3	24	36	47	39	50		TCRBV24-01,TCRBV24-or09_02												CASSLGTGIYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGTCATCGGGCTAGCGTCGGCACAGATACGCAGTATTTTGGCCCA	CASSLGHRASVGTDTQYF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	6	1	9	3	19	35	50	44	53	TCRBV07,TCRBV11					01,02								CASSLGHRASVGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGCAGGGGGCCAGTTTTCTTCCCGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	2.1396258711333903E-4		58	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	0	4	4	14	23	37	49	41	63		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGACCCGGGACTAGCGGGAGTCCCCATGAGCAGTTCTTCGGGCCA	CASSRPGTSGSPHEQFF	In	VDJ	1	21	2.1396258711333903E-4	2.461322081575246E-4	51	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	2	8	6	5	19	31	51	37	56		TCRBV05-06,TCRBV05-07												CASSRPGTSGSPHEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGCAGGGGGTGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	2.2415128173778375E-4		41	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	1	8	0	3	26	-1	49	43	52		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCAGCCAGGGGGGAGGGGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	2.2415128173778375E-4		53	TCRBV03						TCRBJ02	TCRBJ02-01	01	2	4	1	3	5	7	26	41	53	46	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.2415128173778375E-4		35	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	6	0	26	38	-1	44	47		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCGTTTCCGACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSRFRQGNQPQHF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	4	7	0	23	35	-1	42	50	TCRBV06,TCRBV10													CASSRFRQGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGATCGTCTAGCGGGTGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	2.2415128173778375E-4		47	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	4	6	7	2	19	33	48	40	50		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGTCGTTACTACGAGCAGTACTTCGGGCCG	CSASRRYYEQYF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	9	3	7	0	26	37	-1	44	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRRYYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTTCCCAGGGAAGGTACTATGGCTACACCTTCGGTTCG	CSAISQGRYYGYTF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	3	5	5	26	36	46	41	51		TCRBV20-01,TCRBV20-or09_02												CSAISQGRYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGTGGACAGGGGATTGGGACCCAGTACTTCGGGCCA	CATSDGGQGIGTQYF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	2	7	3	5	24	39	51	42	56		TCRBV24-01,TCRBV24-or09_02												CATSDGGQGIGTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCTCAGCTCCAGCTCCTACGAGCAGTACTTCGGGCCG	XASSLSSSSYEQYF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	6	4	5	0	3	6	20	31	37	34	43	TCRBV07,TCRBV17,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSLSSSSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAGTCGGGACAGGGTGACCAGTTCTTCGGGCCA	YASSQSGQGDQFF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	13	3	4	22	36	48	39	52	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01												YASSQSGQGDQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAAGGACAGGGGGAGGCATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	2.3433997636222847E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	1	6	1	4	23	38	49	39	53	TCRBV09,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTAAGGAGCTTGGAGGGGGCAAAGCTAACTATRGCTACACCTTCGGTTCG	CASSKELGGGKANYXYTF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	0	0	12	4	23	34	53	46	57	TCRBV02,TCRBV09													CASSKELGGGKANYXYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGGACTCSGCCRTGTATCTCTGTGCCAGCAGCTTAAGGATGGGGGTGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	2.4452867098667317E-4		47	unresolved						TCRBJ02	TCRBJ02-01	01	2	6	1	3	5	3	20	35	45	40	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGGGCAGGACCGGGTTTATTAGAACACTGAAGCTTTCTTTGGACAA	CSATGQDRVY*NTEAFF	Stop	VDJ	1	24	2.4452867098667317E-4		51	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	7	0	1	1	16	26	36	42	37	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATGQDRVY*NTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGAGAGTGGGGCAGATACGCAGTATTTTGGCCCA	CSARGESGADTQYF	In	VDJ	1	24	2.4452867098667317E-4	2.8129395218002813E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	2	4	0	7	26	-1	44	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGESGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCGTTGAGACCCAATCGAGGTCTTTCTTTGGACAA		Out	VDJ	1	24	2.4452867098667317E-4		38	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	9	11	1	12	16	1	24	33	53	49	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	1	24	2.4452867098667317E-4	2.8129395218002813E-4	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	30	42	55	43	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSPSGRASRNNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACCCCTTACACCATATATTTTGGAGAG	CASSLTPYTIYF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	36	TCRBV12						TCRBJ01	TCRBJ01-03	01	3	2	7	8	0	5	26	-1	43	40	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPYTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCCACCAGGGACTAGCGGGTCCTACGAGCAGTACTTCGGGCCG	CASSRPPGTSGSYEQYF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	4	1	8	0	26	39	-1	47	59		TCRBV03-01,TCRBV03-02				01,02								CASSRPPGTSGSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGGACAGGGGATCAGTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	25	2.547173656111179E-4		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	2	2	2	7	26	37	49	39	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGGTAGGGGCGGCACTGAAGCTTTCTTTGGACAA	CASSEGRGGTEAFF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	4	6	3	22	34	45	40	48		TCRBV12-03,TCRBV12-04												CASSEGRGGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCGTGACAGGGGGTTACTACGAGCAGTACTTCGGGCCG	CASVTGGYYEQYF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	1	3	2	3	22	31	42	33	45	TCRBV09,TCRBV12													CASVTGGYYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTACCTGGGGACAGCAGACGGCTACACCTTCGGTTCG	CATSDYLGTADGYTF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	8	5	5	24	40	52	45	57		TCRBV24-01,TCRBV24-or09_02												CATSDYLGTADGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTAGACCTAGCGGGAGGCACGGGGGGTATTTTGGCCCA	CASSRPSGRHGGYF	In	VDJ	1	25	2.547173656111179E-4	2.9301453352086266E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	1	14	5	8	23	34	50	39	58	TCRBV02,TCRBV09													CASSRPSGRHGGYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTATCCGGAGACAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSVSGDRGNEQFF	In	VDJ	1	26	2.649060602355626E-4	3.0473511486169713E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	6	10	0	26	37	-1	47	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVSGDRGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGCGTTCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	2.649060602355626E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	4	5	0	18	26	-1	43	39	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGGCCACCAGGGACTAGCGGGATTGGCCTACAATGAGCAGTTCTTCGGGCCA	CSVGHQGLAGLAYNEQFF	In	VDJ	1	26	2.649060602355626E-4	3.0473511486169713E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	3	2	10	4	26	33	56	43	60		TCRBV20-01,TCRBV20-or09_02												CSVGHQGLAGLAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGGCGGGCCCGCGAGCGCAGATACGCAGTATTTTGGCCCA	CASSLGGPASADTQYF	In	VDJ	1	26	2.649060602355626E-4	3.0473511486169713E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	4	4	2	10	18	32	39	34	49	TCRBV07,TCRBV11					01,02								CASSLGGPASADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTGTACCCGGACTAGCGGTCTAAGTGGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	2.649060602355626E-4		53	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	5	7	9	10	20	31	50	40	60	TCRBV07,TCRBV23					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTACAGGGGGCGCCGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLQGAPGNQPQHF	In	VDJ	1	26	2.649060602355626E-4	3.0473511486169713E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	0	2	0	5	19	-1	42	33	47	TCRBV05,TCRBV07													CASSLQGAPGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGCCCCACATACAATGAGCAGTTCTTCGGGCCA	CASSLGPTYNEQFF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	4	0	6	26	-1	44	40	50		TCRBV12-03,TCRBV12-04												CASSLGPTYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACCCCGACAGGGCTACGAGCAGTACTTCGGGCCG	CASSQEPRQGYEQYF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	3	5	0	23	40	-1	45	52	TCRBV01,TCRBV04													CASSQEPRQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCAGGGGGTTGGAATCAGCCCCAGCATTTTGGTGAT	CSAREAGGWNQPQHF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	1	4	2	4	26	40	49	42	53		TCRBV20-01,TCRBV20-or09_02												CSAREAGGWNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTCGGGGCGGAGTTCCCCAGCATTTTGGTGAT	CASSFRGGVPQHF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	3	7	0	10	2	6	22	36	43	38	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRGGVPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCATTACGGGGAGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASITGRYSNQPQHF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	9	1	0	5	2	23	33	44	38	46	TCRBV06,TCRBV10													CASITGRYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGACKCRGCYRTGTAYCTSTGTGCCAGCAGCTTAAAGGACGGATTGCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	2.750947548600073E-4		46	unresolved						TCRBJ02	TCRBJ02-07	01	5	1	7	2	5	8	18	30	39	35	47	TCRBV07,TCRBV15			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGGAGGGCTACGGGGGAGGGTGGACAGATACGCAGTATTTTGGCCCA	CASSLEEGYGGGWTDTQYF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	0	3	12	3	18	35	54	47	57	TCRBV07,TCRBV11													CASSLEEGYGGGWTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGCGGGGGCTGGGAGGAAACACCATATATTTTGGAGAG	CASRRGLGGNTIYF	In	VDJ	1	28	2.8528344948445205E-4	3.281762775433662E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	7	2	4	0	6	24	-1	42	35	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASRRGLGGNTIYF+X+TCRBJ01-03		TCRBD02-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAGGAGAGACCCAGTACTTCGGGCCA	CSARDLGETQYF	In	VDJ	1	28	2.8528344948445205E-4	3.281762775433662E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	5	4	4	3	0	26	40	-1	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCCCTGCAGGGGCCCCTGATGAAGCTTTCTTTGGACAA	CSALPAGAPDEAFF	In	VDJ	1	28	2.8528344948445205E-4	3.281762775433662E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	7	7	7	26	35	48	42	55		TCRBV20-01,TCRBV20-or09_02												CSALPAGAPDEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGACACAGCCCCAGCATTTTGGTGAT	CASSATQPQHF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	6	7	2	0	26	38	-1	40	44		TCRBV03-01,TCRBV03-02												CASSATQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGCAGGGGAGAAACTGAAGCTTTCTTTGGACAA	CSARRGETEAFF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	5	3	4	26	34	43	37	47		TCRBV20-01,TCRBV20-or09_02												CSARRGETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAACTAGGAGGGAGAAGAGATACGCAGTATTTTGGCCCA	CSAELGGRRDTQYF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	0	5	7	5	26	34	47	41	52		TCRBV20-01,TCRBV20-or09_02												CSAELGGRRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCGCTAGAGGGGATTACAAGTTCTTCGGGCCA	CATSAARGDYKFF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	5	2	14	7	6	24	37	49	44	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSAARGDYKFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGTAGACAGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	2.9547214410889676E-4		37	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	3	1	2	1	23	31	40	33	41	TCRBV02,TCRBV09													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACTAGCGGGATGGGTACGCAGTATTTTGGCCCA	CSARDTSGMGTQYF	In	VDJ	1	30	3.056608387333415E-4	3.5161744022503517E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	3	3	8	1	4	26	40	51	41	55		TCRBV20-01,TCRBV20-or09_02												CSARDTSGMGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTTCTCGGGACTGCTTTCTTTGGACAA	CSARFLGTAFF	In	VDJ	1	30	3.056608387333415E-4	3.5161744022503517E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	0	10	11	7	0	26	37	-1	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARFLGTAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAATTAGGACAGGTGACACTGAAGCTTTCTTTGGACAA	CASSLIRTGDTEAFF	In	VDJ	1	30	3.056608387333415E-4	3.5161744022503517E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	3	7	2	24	36	50	43	52		TCRBV24-01,TCRBV24-or09_02												CASSLIRTGDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCGTTAGCGGAAGGTACAATGAGCAGTTCTTCGGGCCA	CASTVSGRYNEQFF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	5	5	4	4	4	26	36	46	40	50		TCRBV03-01,TCRBV03-02				01,02								CASTVSGRYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAATGGCGGGAGGCCTACGAGCAGTACTTCGGGCCG	CSARKWREAYEQYF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	1	2	5	0	26	38	-1	43	51		TCRBV20-01,TCRBV20-or09_02												CSARKWREAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCAGCCGTGAACACTGAAGCTTTCTTTGGACAA	CASSPAVNTEAFF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	4	5	0	1	3	22	34	38	35	41		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATCCTGCAGACGGGGTATTGAGGGAGACCCAGTACTTCGGGCCA	CAISDPADGVLRETQYF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	3	5	11	8	23	35	51	46	59	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDPADGVLRETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCGGACGGGACAGGGAGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	31	3.158495333577862E-4		49	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	3	2	6	2	19	31	46	37	48		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGTMMCCWMYCAGACATCTRTGTACYTCTGTGCCAGCAGTTTACTGAGACAGGGGAATTCACCCCTCCACTTTGGGAAC	CASSLLRQGNSPLHF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	2	7	7	0	28	40	-1	47	55	TCRBV06,TCRBV28													CASSLLRQGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTGGGGTCCAGGGGTGAGCGGGGAGCTGTTTTTTGGAGAA	CASSQVWGPGVSGELFF	In	VDJ	1	32	3.260382279822309E-4	3.7505860290670416E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	2	7	9	4	26	42	57	51	61		TCRBV03-01,TCRBV03-02												CASSQVWGPGVSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACGTCCATTTGGAAGCTTTCTTTGGACAA	CSARGDVHLEAFF	In	VDJ	1	32	3.260382279822309E-4	3.7505860290670416E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	0	7	8	0	9	26	-1	44	39	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGDVHLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGGCAGGGGGCGCCGAGATCCCAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	3.260382279822309E-4		58	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	3	4	13	23	37	49	41	62		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGATGGGACACAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	32	3.260382279822309E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	1	3	2	24	40	49	43	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTCGGCGGGGTGTTAGCCGGGGAGCTGTTTTTTGGAGAA	CASSFGGVLAGELFF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	7	3	6	2	6	36	50	58	52	64	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSFGGVLAGELFF+X+TCRBJ02-02		TCRBD02-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCCAAGCGGGAGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSPSGRVYNEQFF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	0	3	4	1	24	35	49	39	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPSGRVYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAATGCAATCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	3.3622692260667564E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	5	17	3	26	38	58	55	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTCGGGACAGGGCATCAATGAGCAATTCTTCGGGCCA	CSATSGQGINEQFF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	16	4	13	26	36	49	40	62		TCRBV20-01,TCRBV20-or09_02												CSATSGQGINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCTGGGGACAGGGATACGAGCAGTACTTCGGGCCG	CSARAWGQGYEQYF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	4	6	1	26	37	52	43	53		TCRBV20-01,TCRBV20-or09_02												CSARAWGQGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGGGGACKCAGCYWTGTAYYTSTGTGCCAGCAGCTCGAGAGATGGGATGGCAAATACCGGGGAGCTGTTTTTTGGAGAA	CASSSRDGMANTGELFF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	51	unresolved						TCRBJ02	TCRBJ02-02	01	5	0	8	5	9	8	18	30	43	39	51	TCRBV09,TCRBV15			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRDGMANTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGACCGTTCCTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	34	3.4641561723112036E-4		50	TCRBV03						TCRBJ01	TCRBJ01-03	01	5	2	7	5	2	16	26	38	43	40	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCGCGGCTGCGTCGGGGCACTGAAGCTTTCTTTGGACAA	CSAPRLRRGTEAFF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	4	13	0	26	34	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSAPRLRRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGTACCCAAACTAGCGGGAGGCACAATGAGCAGTTCTTCGGGCCA	CSARSTQTSGRHNEQFF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	1	5	9	1	26	38	59	47	60		TCRBV20-01,TCRBV20-or09_02												CSARSTQTSGRHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACTCCCGGGACAGGGTTTGTACGAGCAGTACTTCGGGCCG	CSAPLPGQGLYEQYF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	8	4	26	35	52	43	56		TCRBV20-01,TCRBV20-or09_02												CSAPLPGQGLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCCCCTGCTCTAGCTTCGAGCTTTCTTTGGACAA		Out	VDJ	1	35	3.566043118555651E-4		37	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	4	7	10	9	4	24	33	47	42	51		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATAGGCGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CSARIGGGSYEQYF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	1	0	6	0	26	38	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSARIGGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATACTAAAGCTAACTATGGCTACACCTTCGGTTCG	CSAYTKANYGYTF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	9	0	3	3	26	35	42	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYTKANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCAACAGGCTATGGCTACACCTTCGGTTCG	CATSDPTGYGYTF	In	VDJ	1	37	3.769817011044545E-4	4.336615096108767E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	4	4	3	0	24	39	-1	42	47		TCRBV24-01,TCRBV24-or09_02												CATSDPTGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGCCGGGCAGGGGAACACTGAAGCTTTCTTTGGACAA	CSARDAGQGNTEAFF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	1	7	0	26	40	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSARDAGQGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCATCGGGCGGGAGGGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSHRAGGRTGELFF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	7	0	5	7	3	24	35	51	42	54		TCRBV24-01,TCRBV24-or09_02												CASSHRAGGRTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTAGCGGGAGGGGCCCCACAGATACGCAGTATTTTGGCCCA	CASSPSGRGPTDTQYF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	0	2	1	4	24	36	49	37	53		TCRBV24-01,TCRBV24-or09_02												CASSPSGRGPTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCKRRRGACWSMRSCRTRTATCTCTRCGCCAGCAGCCAAGGAGGCCTTCATACCGGGGAGCTGTTTTTTGGAGAA	XASSQGGLHTGELFF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	11	10	1	5	12	7	25	28	45	40	52	TCRBV04,TCRBV29													XASSQGGLHTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTCTCGGTTTTGGGGGCGAGTGGCTACACCTTCGGTTCG	CASSFSVLGASGYTF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	6	0	7	9	3	22	36	51	45	54	TCRBV07,TCRBV11													CASSFSVLGASGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCCCCGCACAGATACGCAGTATTTTGGCCCA	CATSDFPRTDTQYF	In	VJ	1	39	3.973590903533439E-4	4.571026722925457E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	1	0	0	1	0	5	24	-1	41	-1	46		TCRBV24-01,TCRBV24-or09_02												CATSDFPRTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAATACCCCGGGGGGTTCTACAATGAGCAGTTCTTCGGGCCA	CSAKYPGGFYNEQFF	In	VDJ	1	40	4.0754778497778863E-4	4.6882325363338024E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	3	9	2	26	34	50	43	52		TCRBV20-01,TCRBV20-or09_02												CSAKYPGGFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGCAGACAGGGCCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	4.0754778497778863E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	8	6	3	26	34	47	40	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCTCTAGGGGACAGCGACATGGCTACACCTTCGGTTCG	CASSSRGQRHGYTF	In	VDJ	1	40	4.0754778497778863E-4	4.6882325363338024E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	6	6	4	22	33	46	39	50	TCRBV12,TCRBV21													CASSSRGQRHGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCGATACGGCATCACAGATACGCAGTATTTTGGCCCA	CATSRYGITDTQYF	In	VDJ	1	40	4.0754778497778863E-4	4.6882325363338024E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	9	0	2	6	2	24	36	45	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRYGITDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCGACAAGGAACGGGCCAGCCCCAGCATTTTGGTGAT	CASSRQGTGQPQHF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	42							TCRBJ01	TCRBJ01-05	01	6	2	6	7	2	10	24	35	41	37	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRQGTGQPQHF+X+TCRBJ01-05			TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGGTGATTGGGGACAAAACGAAGCTTTCTTTGGACAA	CASSGDWGQNEAFF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	8	8	4	22	34	48	42	52	TCRBV12,TCRBV21													CASSGDWGQNEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGACTACCCGAGGGCGGCAGTACTTCGGGCCG	CATSDGTTRGRQYF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	9	9	0	10	24	-1	46	39	56		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDGTTRGRQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCAGAGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSESNTGELFF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	42	TCRBV07						TCRBJ02	TCRBJ02-02	01	1	5	5	0	0	1	19	-1	37	35	38		TCRBV07-01,TCRBV07-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSESNTGELFF+TCRBV07-X+TCRBJ02-02	TCRBV07		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGTCAGGGGTTCAAATTTAATGAGCAGTTCTTCGGGCCA	CASSVGQGFKFNEQFF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	7	6	9	24	36	48	42	57	TCRBV09,TCRBV21													CASSVGQGFKFNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGGCAGCTCAATCAGCCCCAGCATTTTGGTGAT	CSARVGQLNQPQHF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	7	0	3	1	4	26	39	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSARVGQLNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCACAGGGTTTTAATGAAAAACTGTTTTTTGGCAGT	CASSLSQGFNEKLFF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	4	5	3	24	36	47	41	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSQGFNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTAGGGACAAGCGGGCGTAACGGAGATACGCAGTATTTTGGCCCA	CATSDLGTSGRNGDTQYF	In	VDJ	1	43	4.381138688511228E-4	5.039849976558838E-4	54	TCRBV24						TCRBJ02	TCRBJ02-03	01	4	0	6	5	4	14	24	38	48	42	62		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLGTSGRNGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGAAAGGGCGCCCAACGGGGGCTTTCTTTGGACAA	CASRKGRPTGAFF	In	VDJ	1	44	4.483025634755675E-4	5.157055789967183E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	11	14	0	26	37	-1	51	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRKGRPTGAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTAAAGGGTTTAGCGGGAGGGCCTTACGAGCAGTACTTCGGGCCG	CASSQDLKGLAGGPYEQYF	In	VDJ	1	44	4.483025634755675E-4	5.157055789967183E-4	57	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	0	4	11	3	24	41	63	52	66		TCRBV03-01,TCRBV03-02												CASSQDLKGLAGGPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGCCCCCCTTGGGACCTCACAGATACGCAGTATTTTGGCCCA	CASSPPWDLTDTQYF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	45							TCRBJ02	TCRBJ02-03	01	4	0	7	2	6	2	36	49	60	55	62	TCRBV04,TCRBV25,TCRBV27,TCRBV28	TCRBV04-02,TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPWDLTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGACACAGGACTAGCGGGGCTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	45	4.584912581000122E-4		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	3	5	2	26	37	54	42	56	TCRBV03,TCRBV12													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTCGGGCTAGCGGGAGCCAAAACCGGGGAGCTGTTTTTTGGAGAA	CSAFGLAGAKTGELFF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	2	5	7	5	26	34	51	41	56		TCRBV20-01,TCRBV20-or09_02												CSAFGLAGAKTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAAGCGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLKRDSYNEQFF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	3	0	4	0	24	36	-1	40	47		TCRBV24-01,TCRBV24-or09_02												CASSLKRDSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCATCAGCCGGGACTAGCGGGAGCTCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	4.584912581000122E-4		55	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	0	2	0	6	4	20	30	50	36	54	TCRBV05,TCRBV23													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATGGGGTTCCAGGGAAGAAAGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	46	4.6867995272445695E-4		55	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	1	8	8	26	41	54	49	62		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGCTAGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.6867995272445695E-4		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	2	0	4	0	26	42	-1	46	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACTAGCGGGTTCTACGAGCAGTACTTCGGGCCG	CSARGTSGFYEQYF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	4	3	0	2	26	-1	50	39	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGTSGFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTTTGGACAGAAACACTACAATGAGCAGTTCTTCGGGCCA	CSASFGQKHYNEQFF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	5	3	4	5	26	37	47	41	52		TCRBV20-01,TCRBV20-or09_02												CSASFGQKHYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCGGGGCCTAGCGGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAISDRGLAGANTGELFF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	54				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	4	0	9	2	23	35	52	44	54	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03				01,02								CAISDRGLAGANTGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCAAGTATGAACACTGAAGCTTTCTTTGGACAA	CASSPSMNTEAFF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	4	4	6	0	0	4	23	-1	38	36	42	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGGGAGCGGGAGGGGGTACAATGAGCAGTTCTTCGGGCCA	CSATGSGRGYNEQFF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	0	4	5	2	26	36	51	41	53		TCRBV20-01,TCRBV20-or09_02												CSATGSGRGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAACAGGGGCGAAACAATGAGCAGTTCTTCGGGCCA	CSASKQGRNNEQFF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	2	5	3	4	26	37	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSASKQGRNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCCGGGTCGTACAGGTCAGCCCCAGCATTTTGGTGAT	CATSPGRTGQPQHF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	4	6	9	0	24	36	-1	45	50		TCRBV24-01,TCRBV24-or09_02												CATSPGRTGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGGCAGACCGGGGGACCCAGTACTTCGGGCCA	CATSDLRADRGTQYF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	3	7	9	0	24	42	-1	51	56		TCRBV24-01,TCRBV24-or09_02												CATSDLRADRGTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCAAGAGGCGGGGAGGGACTGAAGCTTTCTTTGGACAA	XASSKRRGGTEAFF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	5	8	0	22	34	-1	42	49	TCRBV07,TCRBV17,TCRBV23													XASSKRRGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCGGGATGGGGCTGGGAGGTGGTACGCAGTATTTTGGCCCA		Out	VDJ	1	48	4.890573419733463E-4		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	9	1	8	13	3	24	30	49	43	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCGGGACCTGAGGGAGCAGTACTTCGGGCCG	CSARDPRDLREQYF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	0	7	7	5	6	26	40	50	45	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPRDLREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGCGAAGACAGGTCGTCGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	49	4.99246036597791E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	3	6	8	26	37	49	43	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGCCTAGCGGGAGAGACCCAGTACTTCGGGCCA	CASSQDRLAGETQYF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	4	4	4	0	23	40	-1	44	52	TCRBV01,TCRBV04					01,02								CASSQDRLAGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGTCGGCAGAAACAAGAGACCCAGTACTTCGGGCCA	CASSLSRQKQETQYF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	45	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	4	5	2	9	3	24	36	48	45	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRQKQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCTCCGCCCGGGGGCGGGATGAAAAACTGTTTTTTGGCAGT	CASARGRDEKLFF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	39	TCRBV24						TCRBJ01	TCRBJ01-04	01	12	6	0	6	7	3	24	30	43	37	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASARGRDEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATACGGGAGTAGTTCAGTACTTCGGCGCC	CAISDTGVVQYF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	36				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	8	2	11	4	3	23	35	45	39	48	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDTGVVQYF+X+TCRBJ02-04		TCRBD02-01*02	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTAAAGGACAGGGAGAGACCCAGTACTTCGGGCCA	CASSKGQGETQYF	In	VDJ	1	50	5.094347312222358E-4	5.860290670417253E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	4	3	0	22	34	-1	37	45		TCRBV12-03,TCRBV12-04												CASSKGQGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCCAAGGACGGGCTATGGCTACACCTTTGGTTCG	CASSPRTGYGYTF	In	VDJ	1	50	5.094347312222358E-4	5.860290670417253E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	6	1	7	20	5	19	24	35	44	40	63	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRTGYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGTACTGGCCAACCAAAAACATTCAGTACTTCGGCGCC	CASSQRYWPTKNIQYF	In	VDJ	1	51	5.196234258466805E-4	5.977496483825597E-4	48	TCRBV03						TCRBJ02	TCRBJ02-04	01	2	5	4	2	0	10	26	-1	44	41	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRYWPTKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGACTGACACAGGGTATGAACACTGAAGCTTTCTTTGGACAA	CASRLTQGMNTEAFF	In	VDJ	1	51	5.196234258466805E-4	5.977496483825597E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	0	6	2	19	30	42	36	44	TCRBV07,TCRBV11													CASRLTQGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCCGGGAGTACTACGAGCAGTACTTCGGGCCG	CSARDSREYYEQYF	In	VDJ	1	52	5.298121204711252E-4	6.094702297233943E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	2	3	4	2	26	40	50	44	52		TCRBV20-01,TCRBV20-or09_02												CSARDSREYYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACTGGCGCCGCTTACGAGCAGTACTTCGGGCCG	CASSTGAAYEQYF	In	VDJ	1	52	5.298121204711252E-4	6.094702297233943E-4	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	9	0	4	3	6	24	36	42	39	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGAAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGAGGGAGGTCCTTTTACGAGCAGTACTTCGGGCCG	CSAREGGRSFYEQYF	In	VDJ	1	53	5.400008150955699E-4	6.211908110642288E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	1	4	4	6	26	40	50	44	56		TCRBV20-01,TCRBV20-or09_02												CSAREGGRSFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGGCTGAAGAATGGTGAGCAGTTCTTCGGGCCA	CASSFGLKNGEQFF	In	VDJ	1	54	5.501895097200147E-4	6.329113924050633E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	8	0	9	1	10	26	40	45	41	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGLKNGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCGGGCCCTCCCACCTCCGAAAAACTGTTTTTTGGCAGT	CASSHPGPPTSEKLFF	In	VDJ	1	55	5.603782043444594E-4	6.446319737458978E-4	48	TCRBV03						TCRBJ01	TCRBJ01-04	01	3	8	0	8	3	12	26	40	47	43	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPGPPTSEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAAGCGGGAGCAACCTACGAGCAGTACTTCGGGCCG	CSASQAGATYEQYF	In	VDJ	1	56	5.705668989689041E-4	6.563525550867324E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	2	2	3	3	26	37	48	40	51		TCRBV20-01,TCRBV20-or09_02												CSASQAGATYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCCCCCGAAGTCTCATGAACACTGAAGCTTTCTTTGGACAA	CSAAPRSLMNTEAFF	In	VDJ	1	57	5.807555935933488E-4	6.680731364275668E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	2	8	0	8	7	26	34	44	42	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAPRSLMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAGTGTGTGTATACCAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	57	5.807555935933488E-4		55	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	6	5	15	5	24	36	54	51	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCACTACGGACTGGGAAGCAGTTCTTCGGGCCA	CASSPLRTGKQFF	In	VDJ	1	58	5.909442882177935E-4	6.797937177684013E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	11	7	4	26	38	50	45	54		TCRBV12-03,TCRBV12-04				01,02								CASSPLRTGKQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATACAGCGATACAAGAGACCCAGTACTTCGGGCCA	CASSHTAIQETQYF	In	VDJ	1	59	6.011329828422382E-4	6.915142991092358E-4	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	3	3	5	2	1	5	26	40	45	41	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTAIQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGCAGCGGGCCCTTCCCGGGAGACCCAGTACTTCGGGCCA	CASAAGPSRETQYF	In	VDJ	1	59	6.011329828422382E-4	6.915142991092358E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	11	6	4	5	4	10	24	31	41	35	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASAAGPSRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACKCAGCCATGTAYCKSTGTGCCAGCAGCCYTGGACAGGGGTACTACGAGCAGTACTTCGGGCCG	CASSXGQGYYEQYF	In	VDJ	1	61	6.215103720911277E-4	7.149554617909049E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	3	3	2	18	30	42	33	44	TCRBV07,TCRBV15													CASSXGQGYYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGTCGACAAGACACCATATATTTTGGAGAG	CASSQGRQDTIYF	In	VDJ	1	62	6.316990667155724E-4	7.266760431317394E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	6	8	5	2	26	40	49	45	51		TCRBV03-01,TCRBV03-02												CASSQGRQDTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGAATCTGCGGGAGGCGGTTACGCAGTATTTTGGCCCA	CASSLNLREAVTQYF	In	VDJ	1	62	6.316990667155724E-4	7.266760431317394E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	1	8	6	4	18	32	46	38	50	TCRBV07,TCRBV11													CASSLNLREAVTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCGGGACAGCTCTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	63	6.418877613400171E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	0	3	6	26	40	50	43	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGACAGCCGGAAACACCATATATTTTGGAGAG	CSAQTAGNTIYF	In	VDJ	1	63	6.418877613400171E-4	7.383966244725738E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	5	4	3	2	26	34	42	37	44		TCRBV20-01,TCRBV20-or09_02												CSAQTAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGGTCTATGGCTACACCTTCGGTTCG	CSARGQVYGYTF	In	VDJ	1	63	6.418877613400171E-4	7.383966244725738E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	4	4	0	1	26	-1	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSARGQVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCAGCGGGGGGGGAGGTACTGAAGCTTTCTTTGGACAA	CASSPSGGGGTEAFF	In	VDJ	1	63	6.418877613400171E-4	7.383966244725738E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	6	0	5	3	5	23	35	48	38	53	TCRBV09,TCRBV21													CASSPSGGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGGGTTGCAGATACGCAGTATTTTGGCCCA	CASSWGVADTQYF	In	VDJ	1	64	6.520764559644618E-4	7.501172058134083E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	1	4	0	3	26	-1	45	39	48		TCRBV12-03,TCRBV12-04												CASSWGVADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAACGACAGGCGACAAATAATGAAAAACTGTTTTTTGGCAGT	CASSQRQATNNEKLFF	In	VDJ	1	65	6.622651505889066E-4	7.618377871542428E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	4	4	5	7	26	37	48	42	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSQRQATNNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGGGCCAGGCGACGTTCAGCCCCAGCATTTTGGTGAT	CASSPRGPGDVQPQHF	In	VDJ	1	66	6.724538452133513E-4	7.735583684950774E-4	48	TCRBV03						TCRBJ01	TCRBJ01-05	01	4	6	0	6	3	10	26	39	48	42	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGPGDVQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACTAAGACAGGGTGGGCAAACACCATATATTTTGGAGAG	CSATKTGWANTIYF	In	VDJ	1	66	6.724538452133513E-4	7.735583684950774E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	6	6	5	26	34	47	40	52		TCRBV20-01,TCRBV20-or09_02												CSATKTGWANTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCATCGGGGCGGGAGCCCTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	67	6.82642539837796E-4		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	4	8	5	26	40	55	48	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGACTGGGGAGCTGTTTTTTGGAGAA	CSAREGTGELFF	In	VDJ	1	67	6.82642539837796E-4	7.852789498359119E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	0	10	8	1	0	26	40	-1	41	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTATGGGAGTGAGGGTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	67	6.82642539837796E-4		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	2	2	3	8	26	37	45	40	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGAGCCGGGACTTTCCCTACGAGCAGTACTTCGGGCCG	CASRSRDFPYEQYF	In	VDJ	1	69	7.030199290866854E-4	8.087201125175808E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	2	5	3	26	37	48	42	51		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRSRDFPYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTATGACAGGGCCGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	69	7.030199290866854E-4		46	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	0	4	3	19	31	42	35	45		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGATGACAGGGACAGGTACCGGGGAGCTGTTTTTTGGAGAA	CSASRMTGTGTGELFF	In	VDJ	1	70	7.132086237111302E-4	8.204406938584154E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	4	5	10	1	26	37	55	47	56		TCRBV20-01,TCRBV20-or09_02												CSASRMTGTGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGGGACAGGGCCCTGTTTTTTGGAGAA	CATSDRDRALFF	In	VDJ	1	70	7.132086237111302E-4	8.204406938584154E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	14	1	2	24	39	49	40	51		TCRBV24-01,TCRBV24-or09_02												CATSDRDRALFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCAGATGGGGGCGAGCAGTACTTCGGGCCG	CASSSDGGEQYF	In	VDJ	1	71	7.233973183355749E-4	8.321612751992499E-4	36	TCRBV12						TCRBJ02	TCRBJ02-07	01	4	6	1	6	5	0	26	39	-1	44	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDGGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCAGTGCCGAGCGGGAGTAACGGTACGAGCAGTACTTCGGGCCG	CATSAERE*RYEQYF	Stop	VDJ	1	71	7.233973183355749E-4		45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	4	4	6	36	48	60	52	66	TCRBV23,TCRBV24,TCRBV25	TCRBV23-or09_02,TCRBV24-01,TCRBV24-or09_02,TCRBV25-01,TCRBV25-or09_02												CATSAERE*RYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCGGAGGACTAGCGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGGLAGNTGELFF	In	VDJ	1	72	7.335860129600196E-4	8.438818565400844E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	3	2	3	0	18	30	-1	33	45	TCRBV07,TCRBV11													CASSGGLAGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCCCCGCAGTGACTACAATGAGCAGTTCTTCGGGCCA	CASSSPRSDYNEQFF	In	VDJ	1	73	7.437747075844643E-4	8.556024378809189E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	5	3	7	3	26	39	49	46	52		TCRBV12-03,TCRBV12-04												CASSSPRSDYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGATGGCGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	73	7.437747075844643E-4		41	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	0	8	7	1	6	26	40	45	41	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGACCGTGGGGTACCGAAGCTTTCTTTGGACAA	CASRPWGTEAFF	In	VDJ	1	73	7.437747075844643E-4	8.556024378809189E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	6	6	2	8	5	4	23	34	43	39	47	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPWGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGTTTGAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	74	7.53963402208909E-4		40	TCRBV20						TCRBJ01	TCRBJ01-06	01	0	2	8	7	6	0	26	40	-1	46	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAACAGAGACCCAGTACTTCGGGCCA	CSARGTETQYF	In	VDJ	1	74	7.53963402208909E-4	8.673230192217535E-4	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	2	8	4	0	2	26	-1	41	39	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGTETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCTGCCAGGACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPARTANTGELFF	In	VDJ	1	74	7.53963402208909E-4	8.673230192217535E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	0	7	0	18	30	-1	37	43	TCRBV07,TCRBV11													CASSPARTANTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGATCCACGAGCAGTACTTCGGGCCG	CASSQEIHEQYF	In	VDJ	1	75	7.641520968333537E-4	8.790436005625879E-4	36	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	2	8	5	0	3	26	-1	45	43	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEIHEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTCCCGGGACAGGAAATCTACGAGCAGTACTTCGGGCCG	CSFPGQEIYEQYF	In	VDJ	1	75	7.641520968333537E-4	8.790436005625879E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	4	3	5	4	26	32	45	37	49		TCRBV20-01,TCRBV20-or09_02												CSFPGQEIYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGCGGGTTAGGCCCTAATGAGCAGTTCTTCGGGCCA	CASSRGLGPNEQFF	In	VDJ	1	76	7.743407914577984E-4	8.907641819034224E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	4	7	1	9	18	30	36	31	45	TCRBV07,TCRBV11					01,02								CASSRGLGPNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGGGACTAGCGGGAGGGATGGGTGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	77	7.845294860822431E-4		49	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	0	7	2	8	26	34	52	36	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGCCCCCGGGACAGGGGTGAAGGGGTATGGCTACACCTTCGGTTCG	CASSAPGTGVKGYGYTF	In	VDJ	1	78	7.947181807066878E-4	9.142053445850914E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	5	5	8	23	36	51	41	59	TCRBV09,TCRBV12													CASSAPGTGVKGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTCTAGCGGGAGGGCAGATACGCAGTATTTTGGCCCA	CATSESSGRADTQYF	In	VDJ	1	79	8.049068753311325E-4	9.25925925925926E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	0	4	2	0	24	38	-1	40	52		TCRBV24-01,TCRBV24-or09_02												CATSESSGRADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCGAGTGGGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSFRVGTSTDTQYF	In	VDJ	1	79	8.049068753311325E-4	9.25925925925926E-4	48	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	0	8	0	8	3	24	36	48	44	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRVGTSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACACCGGGACTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARTPGLANTGELFF	In	VDJ	1	80	8.150955699555773E-4	9.376465072667605E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	10	0	5	2	26	38	49	43	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTPGLANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAGTCGCTGGAGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	81	8.25284264580022E-4		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	0	4	7	0	24	36	-1	43	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCAACAGGGGACAGGATCGCGGCTACACCTTCGGTTCG	CASSFNRGQDRGYTF	In	VDJ	1	81	8.25284264580022E-4	9.493670886075949E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	4	8	6	5	18	32	46	38	51	TCRBV07,TCRBV11													CASSFNRGQDRGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCAGGAGGGGCCGGACTTAACACTGAAGCTTTCTTTGGACAA	CASSPGGAGLNTEAFF	In	VDJ	1	81	8.25284264580022E-4	9.493670886075949E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	0	2	3	9	19	31	40	34	49	TCRBV05,TCRBV11													CASSPGGAGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCTCCTCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSPLLGSYEQYF	In	VDJ	1	81	8.25284264580022E-4	9.493670886075949E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	2	3	8	0	23	35	-1	43	49	TCRBV09,TCRBV21													CASSPLLGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCATCGCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSPIAYQETQYF	In	VDJ	1	82	8.354729592044667E-4	9.610876699484294E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	7	6	0	6	1	24	36	45	42	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPIAYQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTTGGGGCCAAGCGGAGGCGATCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	82	8.354729592044667E-4		52							TCRBJ02	TCRBJ02-07	01	2	7	0	2	1	15	18	32	38	33	53	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07			TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCACGGCGCGAACACTGAAGCTTTCTTTGGACAA	XASSHGANTEAFF	In	VDJ	1	82	8.354729592044667E-4	9.610876699484294E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	3	9	0	1	1	2	22	36	40	37	42	TCRBV01,TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSHGANTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGTCCCTCTCTCCGCGGGAGTTTCGATGAGCAGTTCTTCGGGCCA	CASSPSLRGSFDEQFF	In	VDJ	1	83	8.456616538289114E-4	9.72808251289264E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	2	8	11	5	18	29	47	40	52	TCRBV07,TCRBV11													CASSPSLRGSFDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCGGCCGGGACTAGCGGGAGTTTAAAGCAGTACTTCGGGCCG	CASSSAGTSGSLKQYF	In	VDJ	1	88	8.96605126951135E-4	0.0010314111579934366	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	2	8	5	5	18	31	50	36	55	TCRBV07,TCRBV11													CASSSAGTSGSLKQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGACCTTACTTAGCAATCAGCCCCAGCATTTTGGTGAT	CSARTLLSNQPQHF	In	VDJ	1	91	9.271712108244692E-4	0.00106657290201594	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	1	7	0	2	6	26	34	40	36	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTLLSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGCCGGACAGTTCAATGAGCAGTTCTTCGGGCCA	CASSEAGQFNEQFF	In	VDJ	1	91	9.271712108244692E-4	0.00106657290201594	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	5	6	6	2	22	34	46	40	48		TCRBV12-03,TCRBV12-04												CASSEAGQFNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTAGGACAGGCTAATGAAAGACTGTTTTTTGGCAGT	CASSVGQANERLFF	In	VDJ	1	92	9.373599054489139E-4	0.0010782934833567744	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	4	13	4	10	22	33	44	37	54	TCRBV09,TCRBV12													CASSVGQANERLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTAACGTTGCACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTLHTGELFF	In	VDJ	1	92	9.373599054489139E-4	0.0010782934833567744	42	unresolved						TCRBJ02	TCRBJ02-02	01	2	3	7	3	1	5	19	33	36	34	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTLHTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAGGGTGACTAGCGGCTCCGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	93	9.475486000733586E-4		55	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	5	0	6	7	18	30	45	36	52	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGGGGTTGGTCGGGATACGCAGTATTTTGGCCCA	CASSQEGVGRDTQYF	In	VDJ	1	96	9.781146839466927E-4	0.0011251758087201125	45	unresolved						TCRBJ02	TCRBJ02-03	01	0	6	1	6	0	8	23	-1	45	40	53	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGVGRDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTAGCTACGAGCAGTACTTCGGGCCG	CASSQVSYEQYF	In	VDJ	2	97	9.883033785711374E-4	0.001136896390060947	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	5	8	3	1	0	26	42	-1	43	46		TCRBV03-01,TCRBV03-02				01,02								CASSQVSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGGACGGGACGAGCAGTACTTCGGGCCG	CSARDLGRDEQYF	In	VDJ	2	97	9.883033785711374E-4	0.001136896390060947	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	1	7	5	4	3	26	40	48	44	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGRDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGCCCAACGACAGGTCTCTCTGGAAACACCATATATTTTGGAGAG	CASSGPTTGLSGNTIYF	In	VDJ	2	99	0.0010086807678200268	0.001160337552742616	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	4	0	8	3	24	36	50	44	53	TCRBV09,TCRBV21													CASSGPTTGLSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGCCGGACAGGGGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	100	0.0010188694624444715		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	3	3	1	24	40	52	43	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGGACGGGGCTAGCGGGACCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	100	0.0010188694624444715		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	4	3	4	8	1	24	30	47	38	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAAACAGACTCAGAAGCACAGATACGCAGTATTTTGGCCCA	CSAENRLRSTDTQYF	In	VDJ	2	101	0.0010290581570689163	0.001183778715424285	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	3	5	0	4	7	26	35	43	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAENRLRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACCGGGACTCCTTACAATGAGCAGTTCTTCGGGCCA	CASSLTGTPYNEQFF	In	VDJ	2	103	0.0010494355463178057	0.001207219878105954	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	4	6	3	24	36	48	42	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLTGTPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCTGTGTACTTSTGTGCCGCCGAAAGAGGTCCTAGCGGGAGGTCCGGGTATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAAERGPSGRSGYSSYNEQFF	In	VDJ	2	103	0.0010494355463178057	0.001207219878105954	63	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	4	1	0	13	11	12	18	42	31	53	TCRBV06,TCRBV10													CAAERGPSGRSGYSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGTGCGGGGCTGATCGAAGCTTTCTTTGGACAA	CASSLGAGLIEAFF	In	VDJ	2	104	0.0010596242409422504	0.0012189404594467885	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	7	3	8	6	6	24	36	48	42	54		TCRBV24-01,TCRBV24-or09_02												CASSLGAGLIEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGTTATTCGGGTCTCCGGGACTTTGCTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	104	0.0010596242409422504		62				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	10	3	17	5	18	33	56	50	61	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGGACTATCTACAATGAGCAGTTCTTCGGGCCA	CASSGTIYNEQFF	In	VDJ	2	105	0.0010698129355666951	0.0012306610407876231	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	9	3	0	1	26	-1	45	38	46		TCRBV12-03,TCRBV12-04				01,02								CASSGTIYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATTACCCCGGGACAGGGGTGAACTACGAGCAGTACTTCGGGCCG	CSANYPGTGVNYEQYF	In	VDJ	2	106	0.0010800016301911399	0.0012423816221284576	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	3	8	4	26	36	54	44	58		TCRBV20-01,TCRBV20-or09_02												CSANYPGTGVNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGACTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CSARVTSGGYEQYF	In	VDJ	2	106	0.0010800016301911399	0.0012423816221284576	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	2	2	3	1	0	26	39	-1	40	52		TCRBV20-01,TCRBV20-or09_02												CSARVTSGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATGTGTACAGGGGGCTGGTGCAGCCCCAGCATTTTGGTGAT	XASSQDVYRGLVQPQHF	In	VDJ	2	107	0.0010901903248155846	0.001254102203469292	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	0	7	5	5	23	40	54	45	59	TCRBV01,TCRBV04													XASSQDVYRGLVQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACTAGCGGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	107	0.0010901903248155846		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	1	3	0	0	0	26	-1	-1	39	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TACCTCTGTGCCAGCAGTGAATATTATTCTAGTAACAGAGATAGGACTAGCGGGAGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEYYSSNRDRTSGRASYNEQFF	In	VDJ	2	107	0.0010901903248155846	0.001254102203469292	75	TCRBV25			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	0	0	20	1	6	23	58	43	59		TCRBV25-01,TCRBV25-or09_02												CASSEYYSSNRDRTSGRASYNEQFF+TCRBV25-X+TCRBJ02-01	TCRBV25	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCTCGACAGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSSRQGATGELFF	In	VDJ	2	109	0.001110567714064474	0.001277543366150961	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	0	4	4	0	23	35	-1	39	49	TCRBV09,TCRBV21													CASSSRQGATGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAGCCGTGAACACTGAAGCTTTCTTTGGACAA	CASSPAVNTEAFF	In	VDJ	2	114	0.0011615111871866976	0.0013361462728551335	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	4	5	0	2	3	26	37	42	39	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCACAGGGGCGAGCAGTACTTCGGGCCG	CASSHHRGEQYF	In	VDJ	2	115	0.0011716998818111423	0.0013478668541959682	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	6	2	0	26	40	-1	42	49		TCRBV03-01,TCRBV03-02												CASSHHRGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAACGGGACACAGGATAGGGGCTGAAGCTTTCTTTGGACAA	CASSLTGHRIGAEAFF	In	VDJ	2	116	0.001181888576435587	0.0013595874355368026	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	6	2	11	26	41	49	43	60		TCRBV12-03,TCRBV12-04												CASSLTGHRIGAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCTACACTGGACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CAISDLHWTGMNTEAFF	In	VDJ	2	116	0.001181888576435587	0.0013595874355368026	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	0	10	1	23	35	53	45	54	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDLHWTGMNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGGTTCTAGCGGGAGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	117	0.0011920772710600318		55	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	0	0	6	3	24	36	54	42	57	TCRBV24,TCRBV27													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGAGGGCATCTGGAAACACCATATATTTTGGAGAG	CASSQERASGNTIYF	In	VDJ	2	118	0.0012022659656844765	0.0013830285982184716	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	11	0	1	0	2	23	-1	45	40	47	TCRBV01,TCRBV04													CASSQERASGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCACCGGGACAGGGGTCTGCGCCAAGAGACCCAGTACTTCGGGCCA	CASSLHRDRGLRQETQYF	In	VDJ	2	121	0.0012328320495578107	0.001418190342240975	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	1	6	6	26	39	55	45	61		TCRBV03-01,TCRBV03-02												CASSLHRDRGLRQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCGGGACTAGCGGGAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	2	125	0.0012735868280555895		43	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	0	2	9	2	0	26	40	-1	42	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGACTCCCAACTCCAGCAGTACTTCGGGCCG	CASSLDSQLQQYF	In	VDJ	2	126	0.0012837755226800343	0.0014767932489451476	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	10	8	3	9	24	36	43	39	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLDSQLQQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGAGACGGGGGCAGCCTACGAGCAGTACTTCGGGCCG	CASSLETGAAYEQYF	In	VDJ	2	129	0.0013143416065533684	0.0015119549929676513	45	unresolved						TCRBJ02	TCRBJ02-07	01	0	6	0	2	3	2	18	35	44	38	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLETGAAYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGAGGTTTCGGCACTGAAGCTTTCTTTGGACAA	CASRGGFGTEAFF	In	VDJ	2	130	0.0013245303011778131	0.0015236755743084857	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	4	0	6	26	-1	43	37	49		TCRBV03-01,TCRBV03-02												CASRGGFGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTAAGGGGACTGCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	130	0.0013245303011778131		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	3	5	3	24	38	49	43	52		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGACGGCCCGTACAATGAGCAGTTCTTCGGGCCA	CSARDPDGPYNEQFF	In	VDJ	2	131	0.0013347189958022579	0.0015353961556493201	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	1	7	4	3	6	26	40	47	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPDGPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCAGGCTATCGGGGAGCTGTTTTTTGGAGAA	CASSHQAIGELFF	In	VDJ	2	133	0.0013550963850511473	0.0015588373183309892	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	4	7	1	4	26	40	45	41	49		TCRBV03-01,TCRBV03-02												CASSHQAIGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGACAGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSDRGSYNEQFF	In	VDJ	2	134	0.001365285079675592	0.0015705578996718238	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	1	0	1	24	-1	44	38	45		TCRBV24-01,TCRBV24-or09_02												CASSDRGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGGACCGGGACAGGGACCTTCTATGGCTACACCTTCGGTTCG	CASGTGTGTFYGYTF	In	VDJ	2	137	0.0013958511635489262	0.0016057196436943273	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	0	3	4	8	5	24	31	48	39	53		TCRBV24-01,TCRBV24-or09_02												CASGTGTGTFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGACAGGGGGTAGGGGAGCAGTACTTCGGGCCG		Out	VDJ	2	139	0.0014162285527978156		37	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	1	7	0	5	24	-1	44	35	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCGGGAGGTCCCCTATGGCTACACCTTCGGTTCG	CASSQGREVPYGYTF	In	VDJ	2	140	0.0014264172474222603	0.0016408813877168307	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	8	1	4	2	4	26	42	51	44	55		TCRBV03-01,TCRBV03-02												CASSQGREVPYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGGAAGGAGACTAGCGGGAGGCCCACTCAGTTCTTCGGGCCA	CSARVGKETSGRPTQFF	In	VDJ	2	141	0.001436605942046705	0.0016526019690576653	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	1	13	10	6	26	39	62	49	68		TCRBV20-01,TCRBV20-or09_02												CSARVGKETSGRPTQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGAGTCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	143	0.0014569833312955945		37	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	8	2	6	0	1	26	-1	45	39	46		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACTAGCTAGGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	147	0.0014977381097933734		46	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	7	2	0	6	26	-1	49	42	55		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATCGACAGGGAAAATGGCTACACCTTCGGTTCG	CASSIDRENGYTF	In	VDJ	3	162	0.001650568529160044	0.0018987341772151898	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	6	3	3	26	38	48	41	51		TCRBV12-03,TCRBV12-04												CASSIDRENGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGACCTTAATGAGCAGTTCTTCGGGCCA	CSAGDLNEQFF	In	VDJ	3	164	0.0016709459184089334	0.0019221753398968588	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	0	7	7	1	3	26	35	41	36	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGDLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGGTTACGAGCAGTACTTCGGGCCG	CSARQGYEQYF	In	VDJ	3	165	0.0016811346130333781	0.0019338959212376935	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	4	0	1	26	-1	43	38	44		TCRBV20-01,TCRBV20-or09_02												CSARQGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCTTGGGGCCTGGAAACACCATATATTTTGGAGAG	CASSLLGPGNTIYF	In	VDJ	3	167	0.0017015120022822676	0.0019573370839193623	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	7	0	2	5	0	24	36	-1	41	46		TCRBV24-01,TCRBV24-or09_02												CASSLLGPGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCACACCCTAGGGACCACTGAAGCTTTCTTTGGACAA	CSAPHTLGTTEAFF	In	VDJ	3	173	0.0017626441700289359	0.0020276605719643692	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	7	4	12	0	26	35	-1	47	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPHTLGTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACACCTATTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVHLLNTGELFF	In	VDJ	3	177	0.0018033989485267147	0.0020745428973277073	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	3	6	2	1	7	26	42	46	43	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVHLLNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATCCCATAAAGCTTTCTTTGGACAA	CSARESHKAFF	In	VDJ	3	178	0.0018135876431511595	0.002086263478668542	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	4	6	9	4	2	26	40	46	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARESHKAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGTAGGCTTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	182	0.0018543424216489383		40	TCRBV24						TCRBJ02	TCRBJ02-07	01	5	5	4	2	3	4	24	37	43	40	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGGGAGGCAGACCTGGAAACACCATATATTTTGGAGAG	CASSVGGRPGNTIYF	In	VDJ	3	192	0.0019562293678933853	0.002250351617440225	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	9	1	2	2	5	24	36	44	38	49	TCRBV09,TCRBV21													CASSVGGRPGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGCTCTTAGGGTCGGGAAGCACTGAAGCTTTCTTTGGACAA	CASSLALLGSGSTEAFF	In	VDJ	3	193	0.00196641806251783	0.0022620721987810597	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	3	4	11	2	26	43	59	54	61		TCRBV12-03,TCRBV12-04												CASSLALLGSGSTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCGGGGACGACACTGAAGCTTTCTTTGGACAA	CASSPGDDTEAFF	In	VDJ	3	193	0.00196641806251783	0.0022620721987810597	39	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	7	3	4	1	24	36	45	40	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGDDTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCTAGACCGGGACTACCCAGAGACCCAGTACTTCGGGCCA	XASSLDRDYPETQYF	In	VDJ	3	197	0.002007172841015609	0.0023089545241443974	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	9	4	2	3	22	39	48	41	51	TCRBV04,TCRBV07,TCRBV17					01,02								XASSLDRDYPETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCAGGGGGTGAGCAGTTCTTCGGGCCA	CASSQDPGGEQFF	In	VDJ	3	203	0.0020683050087622772	0.0023792780121894047	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	9	2	0	26	43	-1	45	52		TCRBV03-01,TCRBV03-02												CASSQDPGGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCCCGGGACAGGGGGCCGATTGAACACTGAAGCTTTCTTTGGACAA	CASSPGTGGRLNTEAFF	In	VDJ	3	217	0.0022109467335045033	0.002543366150961088	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	0	0	2	4	23	36	50	38	54	TCRBV01,TCRBV23													CASSPGTGGRLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCTTAGGACTAGCGGGATGGGAAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSHLRTSGMGRTGELFF	In	VDJ	3	221	0.002251701512002282	0.0025902484763244255	57	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	1	3	5	5	8	24	38	55	43	63		TCRBV03-01,TCRBV03-02												CASSHLRTSGMGRTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTCGGGACAGGGCATCAATGAGCAGTTCTTCGGGCCA	CSATSGQGINEQFF	In	VDJ	3	223	0.0022720789012511716	0.0026136896390060948	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	6	4	3	26	36	49	40	52		TCRBV20-01,TCRBV20-or09_02												CSATSGQGINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCCGGACTAGCGGGAGGGTGGGATACGCAGTATTTTGGCCCA	CATSDAGLAGGWDTQYF	In	VDJ	4	237	0.0024147206259933977	0.002777777777777778	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	1	0	6	4	3	24	38	57	42	60		TCRBV24-01,TCRBV24-or09_02												CATSDAGLAGGWDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGATTAGGGTCCGGCCCTGGGAGTTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	238	0.0024249093206178424		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	2	4	11	2	18	34	50	45	52	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATAAGCATGCGATGGGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	4	240	0.002445286709866732		53	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	2	0	13	0	26	38	-1	51	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTATCCGATCCTCCTACGAGCAGTACTTCGGGCCG	CASSSIRSSYEQYF	In	VDJ	4	267	0.0027203814647267393	0.003129395218002813	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	9	0	1	7	24	36	40	37	47		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSIRSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCACAGGGAAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPQGRGNTEAFF	In	VDJ	4	282	0.00287321188409341	0.0033052039381153307	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	2	6	24	36	44	38	50		TCRBV24-01,TCRBV24-or09_02												CASSPQGRGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCACATGGAGGACAGATTAATCAGCCCCAGCATTTTGGTGAT	CSAAHGGQINQPQHF	In	VDJ	4	289	0.002944532746464523	0.0033872480075011722	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	10	3	26	34	50	44	53		TCRBV20-01,TCRBV20-or09_02												CSAAHGGQINQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCATGGCAGGGGGCCTTTGCCAACTACGAGCAGTACTTCGGGCCG	CASSLAWQGAFANYEQYF	In	VDJ	5	313	0.003189061417451196	0.0036685419596812004	54				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	3	4	9	18	35	47	39	56	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAWQGAFANYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAATGGCTAAACAGCCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	317	0.003229816195948975		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	5	4	11	3	22	34	49	45	52	TCRBV09,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTTACGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSAVTGSNQPQHF	In	VDJ	5	329	0.0033520805314423115	0.0038560712611345523	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	3	1	5	0	26	34	-1	39	44		TCRBV20-01,TCRBV20-or09_02												CSAVTGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAGACCTGGGGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSLRPGGAKNIQYF	In	VDJ	5	351	0.0035762318131800953	0.004113924050632912	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	9	1	1	6	0	18	33	-1	39	45	TCRBV07,TCRBV11													CASSLRPGGAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGATAGGACAGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSDRTGVNTEAFF	In	VDJ	6	374	0.003810571789542324	0.004383497421472105	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	4	0	3	2	23	36	46	39	48	TCRBV09,TCRBV21													CASSDRTGVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCGGGGGGACTAGCGGGACGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	6	387	0.003943024819660105		53	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	0	3	4	6	3	26	39	58	45	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATTCGGACAGGGGGAGGTACTGAAGCTTTCTTTGGACAA	CSARIRTGGGTEAFF	In	VDJ	6	396	0.004034723071280107	0.004641350210970464	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	1	5	4	4	26	38	52	42	56		TCRBV20-01,TCRBV20-or09_02												CSARIRTGGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACTAGCGGGCGGTACCAAGAGACCCAGTACTTCGGGCCA	CSAGTSGRYQETQYF	In	VDJ	6	402	0.004095855239026776	0.004711673699015471	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	4	0	0	4	26	-1	47	35	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGTSGRYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCCCCCGGGACGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDGSTDTQYF	In	VDJ	7	420	0.004279251742266781	0.004922644163150493	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	7	0	4	3	18	30	39	34	42	TCRBV11,TCRBV15			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDGSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCAGACTAGCGGGGGCCACTACGAGCAGTACTTCGGGCCG	CASSQTSGGHYEQYF	In	VDJ	7	461	0.0046969882218690145	0.005403187998124707	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	3	2	3	26	38	52	40	55	TCRBV12,TCRBV21													CASSQTSGGHYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGCGGGGTGTTAGCCGGGGAGCTGTTTTTTGGAGAA	CASSFGGVLAGELFF	In	VDJ	11	679	0.0069181236499979626	0.007958274730426628	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	7	3	6	4	6	24	36	46	40	52		TCRBV24-01,TCRBV24-or09_02												CASSFGGVLAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCTGGCGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CSARDLWRPSTDTQYF	In	VDJ	12	763	0.007773973998451318	0.008942803563056727	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	0	6	3	26	40	50	46	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLWRPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGACTAGCGGGAGAGTCTATGAGCAGTTCTTCGGGCCA	CSARPTSGRVYEQFF	In	VDJ	12	776	0.007906427028569099	0.009095171120487576	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	2	2	8	2	5	26	38	52	40	57		TCRBV20-01,TCRBV20-or09_02												CSARPTSGRVYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCTTTCCGGGGAGCTGTTTTTTGGAGAA	CASSFLSGELFF	In	VDJ	27	1733	0.017657007784162692	0.020311767463666197	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	10	6	3	2	24	36	41	39	43		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFLSGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTCGGGCAGGAAGATTGAACACTGAAGCTTTCTTTGGACAA	CASSQGRAGRLNTEAFF	In	VDJ	39	2499	0.025461547866487345	0.029289732770745428	51	unresolved						TCRBJ01	TCRBJ01-01	01	1	4	4	0	6	5	23	39	49	45	54	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRAGRLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGCCGCGGACAACATAGCAATCAGCCCCAGCATTTTGGTGAT	CSASGRGQHSNQPQHF	In	VDJ	41	2639	0.026887965113909607	0.03093061415846226	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	6	0	7	3	26	37	49	44	52		TCRBV20-01,TCRBV20-or09_02												CSASGRGQHSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAACGGGGTTCCAAGAGACCCAGTACTTCGGGCCA	CASSETGFQETQYF	In	VDJ	42	2737	0.02788645718710519	0.03207923112986404	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	3	1	1	2	23	38	44	39	46	TCRBV02,TCRBV09													CASSETGFQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATGGGTCTCCCTCCGAGCAGTACTTCGGGCCG	CASSHGSPSEQYF	In	VDJ	43	2748	0.02799853282797408	0.03220815752461322	39	unresolved						TCRBJ02	TCRBJ02-07	01	3	0	9	6	1	8	23	37	41	38	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHGSPSEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATATGCCCTCGCGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSHMPSRGNTEAFF	In	VDJ	46	2984	0.030403064759343033	0.03497421472105017	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	1	9	0	26	40	-1	49	55		TCRBV03-01,TCRBV03-02												CASSHMPSRGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCGAGCGGGAGTAACGGTACGAGCAGTACTTCGGGCCG	CATSAERE*RYEQYF	Stop	VDJ	48	3110	0.031686840282023065		45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	4	3	6	24	37	48	40	54		TCRBV24-01,TCRBV24-or09_02												CATSAERE*RYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCAGGACAGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSAGQANEKLFF	In	VDJ	52	3335	0.033979296572523125	0.03908813877168307	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	4	3	2	0	23	36	-1	38	45	TCRBV09,TCRBV21													CASSAGQANEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGACTAGCCCTCACAGATACGCAGTATTTTGGCCCA	CATSRGLALTDTQYF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	7	2	0	3	18	-1	41	32	44						01,02								CATSRGLALTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTATCGAGATGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CATSVSR*QSRANVLTF	Stop	VDJ	1	36	3.667930064800098E-4		51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	10	5	18	30	44	40	49														CATSVSR*QSRANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAACTTTAACAATGAGCAGTTCTTCGGGCCA	CATSRDNFNNEQFF	In	VDJ	1	40	4.0754778497778863E-4	4.6882325363338024E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	10	5	2	3	18	35	40	37	43						01,02								CATSRDNFNNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCCGACAGGGGGGGAGACCCAGTACTTCGGGCCA	CATSRDPTGGETQYF	In	VDJ	1	64	6.520764559644618E-4	7.501172058134083E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	1	5	3	1	18	35	47	38	48														CATSRDPTGGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGACGGGAGGGTGGCACAGATACGCAGTATTTTGGCCCA	CATSRGREGGTDTQYF	In	VDJ	1	85	8.660390430778009E-4	9.962494139709329E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	0	1	2	2	18	34	44	36	46														CATSRGREGGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGCGGACAGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CATRRTENTGELFF	In	VDJ	2	107	0.0010901903248155846	0.001254102203469292	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	5	1	2	1	18	29	37	31	38														CATRRTENTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTAACTCAGGGGATCAGCCCCAGCATTTTGGTGAT	CATSRGNSGDQPQHF	In	VDJ	2	121	0.0012328320495578107	0.001418190342240975	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	5	6	0	18	34	-1	40	46														CATSRGNSGDQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAATACAGCGGGAGAGGTCGCAGATACGCAGTATTTTGGCCCA	CATNTAGEVADTQYF	In	VDJ	2	125	0.0012735868280555895	0.0014650726676043132	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	6	2	4	4	6	18	28	40	32	46														CATNTAGEVADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGAGGACAGAAGAAAAACTGGGGAGCTGTTTTTTGGAGAA	CATSEDRRKTGELFF	In	VDJ	2	125	0.0012735868280555895	0.0014650726676043132	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	8	2	10	18	30	38	32	48														CATSEDRRKTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACAGCGGGGCCTGGGTACGAGCAGTACTTCGGGCCG	CATSTAGPGYEQYF	In	VDJ	3	172	0.0017524554754044911	0.002015939990623535	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	3	4	1	6	18	31	39	32	45														CATSTAGPGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGTCCTAGCGGGCTACGAGCAGTACTTCGGGCCG	CATSSVLAGYEQYF	In	VDJ	3	208	0.002119248481884501	0.002437880918893577	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	4	3	4	0	18	32	-1	36	44						01,02								CATSSVLAGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCATTGGACTGGGGGAAGACCCAGTACTTCGGGCCA	CATSPLDWGKTQYF	In	VDJ	3	212	0.0021600032603822797	0.002484763244256915	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	5	6	1	6	10	1	18	30	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSPLDWGKTQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGTGGGGACAGGGCACTGAAGCTTTCTTTGGACAA	CATSRWGQGTEAFF	In	VDJ	5	312	0.0031788727228267513	0.0036568213783403658	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	4	3	0	18	32	-1	35	44														CATSRWGQGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGCTCAGGAGGCTACGAGCAGTACTTCGGGCCG	CATSRGSGGYEQYF	In	VDJ	5	344	0.0035049109508089823	0.00403187998124707	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	1	3	7	0	18	32	-1	39	44														CATSRGSGGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCGGCAGGGATTGTTATCTGGAAACACCATATATTTTGGAGAG	CATSRERQGLLSGNTIYF	In	VDJ	6	360	0.003667930064800098	0.004219409282700422	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	1	4	7	18	35	44	39	51														CATSRERQGLLSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGCTATCAATTAAAAACATTCAGTACTTCGGCGCC	CATSRDRLSIKNIQYF	In	VDJ	7	433	0.004411704772384562	0.005075011720581341	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-04	01	0	5	4	4	1	9	18	35	39	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRLSIKNIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01		TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCGGGGTCGGCATACGAGCAGTACTTCGGGCCG	CATSRDSGSAYEQYF	In	VDJ	11	737	0.007509067938215755	0.00863806844819503	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	4	2	6	18	35	42	37	48														CATSRDSGSAYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGACCCGGTTACTCCTACGAGCAGTACTTCGGGCCG	CASRPGYSYEQYF	In	VDJ	5	309	0.003148306638953417	0.0036216596343178623	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	5	0	3	3	18	29	35	32	38						01,02								CASRPGYSYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGCAGGGGGTGTCGATCAGCCCCAGCATTTTGGTGAT	CASSRAGGVDQPQHF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	1	5	4	5	18	30	41	34	46														CASSRAGGVDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGGTCAGGGGGCTTCTACGAGCAGTACTTCGGGCCG	CASSQGSGGFYEQYF	In	VDJ	1	20	2.0377389248889431E-4	2.3441162681669012E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	3	7	2	18	30	45	37	47														CASSQGSGGFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTATACGGGACTGGCACTGAAGCTTTCTTTGGACAA	CASSQVYGTGTEAFF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	10	4	9	2	18	30	45	39	47						01,02								CASSQVYGTGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATTTGACTAGCGGGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	2.547173656111179E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	3	0	5	0	18	30	-1	35	46														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGCAGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSLDGRLNTEAFF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	0	3	1	18	35	42	38	43														CASSLDGRLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCAGGGAGTGGCGCCTACGAGCAGTACTTCGGGCCG	CASSLAGSGAYEQYF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	4	3	2	2	7	18	32	39	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGSGAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTAGCGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSFLAGGSYEQYF	In	VDJ	1	36	3.667930064800098E-4	4.219409282700422E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	1	0	2	0	18	32	-1	34	44														CASSFLAGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGTTAGCGGGGCGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	3.871703957288992E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	3	4	4	3	18	32	44	36	47														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCACGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGHVSNQPQHF	In	VDJ	1	39	3.973590903533439E-4	4.571026722925457E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	1	3	7	0	3	2	18	34	39	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGHVSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACATCTCCGACCGGGGGTATGGCTACACCTTCGGTTCG	CASSHISDRGYGYTF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	5	12	0	18	30	-1	42	48														CASSHISDRGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACGTTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGTLAGELFF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	1	1	7	6	0	5	18	-1	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTLAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTACGGACCAACCAGGCTGGGATAGGAGAGACCCAGTACTTCGGGCCA	CASSLRTNQAGIGETQYF	In	VDJ	1	42	4.2792517422667807E-4	4.922644163150492E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	0	8	4	15	4	18	33	52	48	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRTNQAGIGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCCCGGAAAAGCGGGAGTAAGAGCCCCCTACGAGCAGTACTTCGGGCCG	CASRPGKAGVRAPYEQYF	In	VDJ	1	43	4.381138688511228E-4	5.039849976558838E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	2	2	9	9	18	29	46	38	55														CASRPGKAGVRAPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATCCACGGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLIHGSNTGELFF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	0	5	1	18	33	42	38	43						01,02								CASSLIHGSNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGTCAGATTAACTATGGCTACACCTTCGGTTCG	CASSLSQINYGYTF	In	VDJ	1	46	4.6867995272445695E-4	5.391467416783872E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	4	5	1	4	2	18	32	39	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSQINYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTATCGAATGATAGCGGGAGGTAATGAGCAGTTCTTCGGGCCA	CASSPYRMIAGGNEQFF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	1	7	13	1	18	30	53	43	54														CASSPYRMIAGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCTTAAGGAGTTCGGGACAGCCCCAGCATTTTGGTGAT	CASSTLRSSGQPQHF	In	VDJ	1	50	5.094347312222358E-4	5.860290670417253E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	8	3	7	13	0	18	30	-1	43	48														CASSTLRSSGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAGAGGCTCGGGGGTACGAGCAGTACTTCGGGCCG	CASSGEARGYEQYF	In	VDJ	1	51	5.196234258466805E-4	5.977496483825597E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	4	9	0	18	30	-1	39	45														CASSGEARGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCAGACGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPDGGSSYNEQFF	In	VDJ	1	55	5.603782043444594E-4	6.446319737458978E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	1	0	8	2	18	30	45	38	47														CASSPPDGGSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCAACCCAGGGCGTCCCAGAAGCTTTCTTTGGACAA	CASSFPTQGVPEAFF	In	VDJ	1	55	5.603782043444594E-4	6.446319737458978E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	8	7	7	18	32	44	39	51														CASSFPTQGVPEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGCCCGCCACGAACACTGAAGCTTTCTTTGGACAA	CASSLAPATNTEAFF	In	VDJ	1	56	5.705668989689041E-4	6.563525550867324E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	9	0	1	0	9	18	-1	35	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPATNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGACAGGGGGCGGCGTGAAGCTTTCTTTGGACAA	CASSRDRGRREAFF	In	VDJ	1	67	6.82642539837796E-4	7.852789498359119E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	7	3	4	18	30	43	33	47														CASSRDRGRREAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAGGCGGGAGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	68	6.928312344622407E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	1	4	4	0	18	32	-1	36	44														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCGTTACTCTTACTAGCGAGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	69	7.030199290866854E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	6	3	13	4	18	30	50	43	54						01,02								X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAAACGGGACAGGGAATCGGGGAGCTGTTTTTTGGAGAA	CASSETGQGIGELFF	In	VDJ	1	69	7.030199290866854E-4	8.087201125175808E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	7	5	3	18	30	44	35	47														CASSETGQGIGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCGACTAGCGGAGATACGCAGTATTTTGGCCCA	CASSSPTSGDTQYF	In	VDJ	1	74	7.53963402208909E-4	8.673230192217535E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	5	5	4	0	18	31	-1	35	44						01,02								CASSSPTSGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCACGCCGCCCGGGAGGGCATTAGGCGGGGAGCTGTTTTTTGGAGAA	CASTTPPGRALGGELFF	In	VDJ	1	86	8.762277377022456E-4	0.0010079699953117675	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	8	0	7	10	7	18	28	46	38	53														CASTTPPGRALGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGCACAGACCCACAGATACGCAGTATTTTGGCCCA	CASSLTHRPTDTQYF	In	VDJ	1	90	9.169825162000245E-4	0.0010548523206751054	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	5	2	4	3	18	33	41	37	44														CASSLTHRPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGCGACAGGTCCGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLGATGPGQETQYF	In	VDJ	1	90	9.169825162000245E-4	0.0010548523206751054	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	4	2	4	7	18	34	44	38	51														CASSLGATGPGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGGACTCTGGGGGTCAGCCCCAGCATTTTGGTGAT	CASSKDSGGQPQHF	In	VDJ	1	91	9.271712108244692E-4	0.00106657290201594	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	6	1	6	9	0	18	30	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKDSGGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCACAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLDHRGNEQFF	In	VDJ	1	95	9.67925989322248E-4	0.001113455227379278	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	2	6	2	0	18	35	-1	37	44														CASSLDHRGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTACAGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSFTGGTYEQYF	In	VDJ	2	103	0.0010494355463178057	0.001207219878105954	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	1	2	1	2	18	32	41	33	43														CASSFTGGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGACCGCACCTCCCTCGAAAAACTGTTTTTTGGCAGT	CASSRDRTSLEKLFF	In	VDJ	2	150	0.0015283041936667073	0.0017580872011251757	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	2	7	8	3	12	18	30	36	33	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDRTSLEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACAGGCCTTCATGAACACTGAAGCTTTCTTTGGACAA	CASSRQAFMNTEAFF	In	VDJ	2	159	0.0016200024452867098	0.0018635724331926863	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	0	1	6	18	30	37	31	43														CASSRQAFMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGAAAACAGGGTGGCACACTGAAGCTTTCTTTGGACAA	CASSWKTGWHTEAFF	In	VDJ	2	161	0.0016403798345355992	0.0018870135958743554	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	3	5	4	18	31	42	36	46														CASSWKTGWHTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCTATCCGGGCAAAAACATTCAGTACTTCGGCGCC	CASSLYPGKNIQYF	In	VDJ	3	166	0.0016913233076578228	0.001945616502578528	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	8	4	3	7	0	18	30	-1	37	41						01,02								CASSLYPGKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGAATAGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLNSGSSYEQYF	In	VDJ	3	167	0.0017015120022822676	0.0019573370839193623	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	2	0	6	0	18	29	-1	35	44														CASSLNSGSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGGGAGGGACTAGCGGGAAGTACAATGAGCAGTTCTTCGGGCCA	CASSLKGGTSGKYNEQFF	In	VDJ	3	184	0.0018747198108978278	0.002156586966713549	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	0	3	4	6	2	18	33	52	39	54														CASSLKGGTSGKYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCAGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSFQGQGNTEAFF	In	VDJ	3	184	0.0018747198108978278	0.002156586966713549	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	1	3	0	18	32	-1	35	44														CASSFQGQGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGTCGGAGGGACGGATGAGCAGTTCTTCGGGCCA	CASSLRVGGTDEQFF	In	VDJ	3	207	0.002109059787260056	0.002426160337552743	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	0	8	6	4	18	33	45	39	49														CASSLRVGGTDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGGCTCGGGGATGAGCAGTTCTTCGGGCCA	CASSLVGLGDEQFF	In	VDJ	3	211	0.002149814565757835	0.0024730426629160805	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	8	7	0	18	34	-1	41	46														CASSLVGLGDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATGGACAGGGTGACTACGAGCAGTACTTCGGGCCG	CASSHGQGDYEQYF	In	VDJ	4	234	0.0023841545421200636	0.0027426160337552744	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	3	3	3	18	30	41	33	44														CASSHGQGDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACGGAGGGGGGCCACCAATGAGCAGTTCTTCGGGCCA	CASSSRRGATNEQFF	In	VDJ	5	312	0.0031788727228267513	0.0036568213783403658	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	5	1	6	5	5	18	31	42	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRRGATNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTTAAAGTCAACCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	8	486	0.004951705587480132		46	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	4	3	7	2	11	1	18	31	44	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGACTAGCGGCCACAGATACGCAGTATTTTGGCCCA	CASSRLAATDTQYF	In	VDJ	11	717	0.007305294045726862	0.008403656821378341	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	5	2	1	1	18	30	40	31	41						01,02								CASSRLAATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGGGGGGTGGGTGAAAAACTGTTTTTTGGCAGT	CASSFRGVGEKLFF	In	VDJ	12	788	0.008028691364062436	0.00923581809657759	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	7	1	4	18	32	40	33	44														CASSFRGVGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTTCAGGGACTACCTTGCAGTACTTCGGGCCG	CASSLGSGTTLQYF	In	VDJ	15	968	0.009862656396462485	0.0113455227379278	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	9	9	5	4	18	34	46	39	50						01,02								CASSLGSGTTLQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCTAGCGGAGGAAAAAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	2.750947548600073E-4		49	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	5	2	0	9	26	-1	49	42	58						01,02								X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGGGCGACAGGGGCTAACGAGCAGTACTTCGGGCCG	CASGATGANEQYF	In	VDJ	1	28	2.8528344948445205E-4	3.281762775433662E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	5	3	3	26	37	48	40	51														CASGATGANEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCCGTTTCAGGGACACCCTCCCGGCCATGAGCAGTACTTCGGGCCG		Out	VDJ	2	108	0.0011003790194400293		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	6	7	8	13	26	34	48	42	61														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTCTATGTGATCATAAGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	108	0.0011003790194400293		53	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	0	5	4	2	13	0	26	43	-1	56	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTCACGGCAGGATTTGGGTTGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	332	0.0033826466153156457		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	4	4	8	5	11	26	32	41	37	52														X+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGATCAGGAGCTACACCTTCGGTTCG	CASGLIRSYTF	In	VDJ	6	407	0.004146798712149	0.004770276605719644	33	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	9	2	1	26	41	47	43	48														CASGLIRSYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCGAAGCGGAAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	19	1.935851978644496E-4		44	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	6	5	2	3	2	20	33	41	36	43						01,02								X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTCGTGCCGTCCTACGAGCAGTACTTCGGGCCG	CASSFVPSYEQYF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	6	10	0	1	6	2	20	31	39	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFVPSYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCTGAGGGGACGTCTCGGACAGGGGTGGGTGAAAAACTGTTTTTTGGCAGT	CASSPEGTSRTGVGEKLFF	In	VDJ	1	24	2.4452867098667317E-4	2.8129395218002813E-4	57	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	2	7	17	4	20	31	57	48	61														CASSPEGTSRTGVGEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACTAACAGGGGACGCAATCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	2.750947548600073E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	2	0	3	9	20	30	40	33	49														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCTCACTATAGCGGGAGTGGATCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPHYSGSGSGSYNEQFF	In	VDJ	1	40	4.0754778497778863E-4	4.6882325363338024E-4	60	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	2	1	9	10	20	31	49	40	59														CASSPHYSGSGSGSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAAACCGGGACAGAGGGGTACTGAAGCTTTCTTTGGACAA	CASSQSKPGQRGTEAFF	In	VDJ	1	43	4.381138688511228E-4	5.039849976558838E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	5	6	6	20	37	50	43	56														CASSQSKPGQRGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGCCCAATTGACAGAAGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRPIDRRTNTGELFF	In	VDJ	1	50	5.094347312222358E-4	5.860290670417253E-4	54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	5	0	8	5	20	33	46	41	51														CASSRPIDRRTNTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCCGAGGGGGGGAACTATGGCTACACCTTCGGTTCG	CASSPEGGNYGYTF	In	VDJ	1	52	5.298121204711252E-4	6.094702297233943E-4	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	2	6	0	20	31	-1	37	44														CASSPEGGNYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGACAGGGCAAACACCATATATTTTGGAGAG	CASSLDRANTIYF	In	VDJ	1	61	6.215103720911277E-4	7.149554617909049E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	3	6	3	1	20	31	42	34	43														CASSLDRANTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTTCGGGACTAGCGGGAGCGGTAGGGGAGCAGTTCTTCGGGCCA	CASSQSSGLAGAVGEQFF	In	VDJ	1	64	6.520764559644618E-4	7.501172058134083E-4	54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	2	10	3	8	20	37	54	40	62														CASSQSSGLAGAVGEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGAGGAGATCCCGGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	115	0.0011716998818111423		49	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	5	10	0	20	31	-1	41	52						01,02								X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTTTGGACAGGGGCGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	154	0.0015690589721644862		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	0	3	2	20	32	44	35	46														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCGTCTGGGGATCAGCCCCAGCATTTTGGTGAT	CASSPSGDQPQHF	In	VDJ	3	188	0.0019154745893956067	0.002203469292076887	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	6	6	2	5	7	0	20	31	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSGDQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGTTCTAATAGAGGGAGCGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQSVLIEGAGANVLTF	In	VDJ	4	256	0.0026083058238578474	0.0030004688232536333	57	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	9	2	4	12	2	20	37	54	49	56														CASSQSVLIEGAGANVLTF+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAAAACAGGGGGTAGCGGGACCTCCTACGAGCAGTACTTCGGGCCG	CASRKTGGSGTSYEQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	3	1	0	4	9	23	34	46	38	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRKTGGSGTSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTTTGGACAGGGGGCGGCCGAGCAGTACTTCGGGCCG	CASSYFGQGAAEQYF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	0	6	4	3	23	37	52	41	55														CASSYFGQGAAEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGGCACCCGAGCGGGCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGAPERASSYNEQFF	In	VDJ	1	18	1.833965032400049E-4	2.109704641350211E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	6	4	0	10	4	23	32	48	42	52						01,02								CASGAPERASSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCCCCCGGGCCCCCTAGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	2.1396258711333903E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	10	8	0	6	7	7	23	30	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGGTCGATGAACACTGAAGCTTTCTTTGGACAA	CASSRSMNTEAFF	In	VDJ	1	22	2.2415128173778375E-4	2.5785278949835914E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	4	0	0	4	23	-1	38	34	42														CASSRSMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGGTGAGGGCAGGGAGGCGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.2415128173778375E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	1	6	11	2	23	37	54	48	56														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTCCACCCAGGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASTSTQGTYNEQFF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	2	8	2	23	33	46	41	48														CASTSTQGTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTAGACAGGGAGGTGGGCAGTACTTCGGGCCG	CASSSRQGGGQYF	In	VDJ	1	23	2.3433997636222847E-4	2.695733708391936E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	9	3	6	23	36	46	39	52														CASSSRQGGGQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGTCAAGGGGCGCCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	2.4452867098667317E-4		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	0	6	5	23	40	51	46	56														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAATTGGGACTAGCGGGAGCCCGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	2.547173656111179E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	0	2	2	6	5	23	30	50	36	55														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGACTCGACAGGGTCGAACACTGAAGCTTTCTTTGGACAA	CAIDSTGSNTEAFF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	2	3	1	7	2	23	30	44	37	46														CAIDSTGSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGACGGTAAGGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVDGKGSSGANVLTF	In	VDJ	1	28	2.8528344948445205E-4	3.281762775433662E-4	54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	5	2	0	10	2	23	35	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDGKGSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACCCCGGGGGGGTCCACCTACGAGCAGTACTTCGGGCCG	CASRTPGGSTYEQYF	In	VDJ	1	31	3.158495333577862E-4	3.633380215658697E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	0	2	5	4	23	34	47	39	51														CASRTPGGSTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGACCGTAATGGAAGCCGTTAATGAAAAACTGTTTTTTGGCAGT	CASRGTVMEAVNEKLFF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	0	7	4	1	15	23	34	40	35	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGTVMEAVNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCGCTAGCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CAISPLAGSTDTQYF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	0	3	0	23	35	-1	38	47														CAISPLAGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACAGGGTCGGGAGATCAGCCCCAGCATTTTGGTGAT	CASRTGSGDQPQHF	In	VDJ	1	35	3.566043118555651E-4	4.102203469292077E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	5	0	7	23	-1	41	34	48														CASRTGSGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGCGACGACGACCATAAACTATGGCTACACCTTCGGTTCG	CASSFATTTINYGYTF	In	VDJ	1	36	3.667930064800098E-4	4.219409282700422E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	4	2	7	2	4	10	23	36	43	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFATTTINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGGCCAGCCGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSLGQPGHNEQFF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	8	0	5	12	1	23	34	50	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQPGHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTTGGGGAGACCCAGTACTTCGGGCCA	CASSYSVGETQYF	In	VDJ	1	38	3.871703957288992E-4	4.453820909517112E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	0	9	5	4	0	23	40	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSVGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAGGGAATTCACATGAGCAGTTCTTCGGGCCA	CASSRGNSHEQFF	In	VDJ	1	40	4.0754778497778863E-4	4.6882325363338024E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	0	8	1	7	23	35	41	36	48														CASSRGNSHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCGACAGGGTCTTGGTCAGCCCCAGCATTTTGGTGAT	CASSYTRQGLGQPQHF	In	VDJ	1	43	4.381138688511228E-4	5.039849976558838E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	3	6	4	6	23	38	49	42	55														CASSYTRQGLGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGCCCGGGACAGCTCCAATGAGCAGTTCTTCGGGCCA	CASSPARDSSNEQFF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	6	7	3	23	35	49	42	52														CASSPARDSSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTCAAATGGAGATACGCAGTATTTTGGCCCA	CASSYSSNGDTQYF	In	VDJ	1	47	4.7886864734890167E-4	5.508673230192217E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	0	10	5	7	0	23	40	-1	47	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSNGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCGGACAGGGGACTCAGCCCCAGCATTTTGGTGAT	CASSLGQGTQPQHF	In	VDJ	1	48	4.890573419733463E-4	5.625879043600563E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	6	4	2	23	34	47	38	49														CASSLGQGTQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTCGTCGGTTCCCCGGGGAGCTGTTTTTTGGAGAA	CASSRRRFPGELFF	In	VDJ	1	49	4.99246036597791E-4	5.743084857008908E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	5	6	6	4	23	35	44	41	48						01,02								CASSRRRFPGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCCAGGGATCTTACGAGCAGTACTTCGGGCCG	CASRPQGSYEQYF	In	VDJ	1	51	5.196234258466805E-4	5.977496483825597E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	4	4	4	23	34	43	38	47														CASRPQGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGGACTTGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRRTWGTGELFF	In	VDJ	1	57	5.807555935933488E-4	6.680731364275668E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	10	4	2	5	23	34	41	36	46						01,02								CASRRTWGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACAGGGGCGGAGGTTCGTGGAGTGAAAAACTGTTTTTTGGCAGT	CASSHRGGGSWSEKLFF	In	VDJ	1	57	5.807555935933488E-4	6.680731364275668E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	7	2	15	23	34	43	36	58														CASSHRGGGSWSEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCCAGCCTACGAGCAGTACTTCGGGCCG	CASSAPAYEQYF	In	VDJ	1	57	5.807555935933488E-4	6.680731364275668E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	5	2	4	0	23	35	-1	39	42														CASSAPAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGCGGGAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGTGELFF	In	VDJ	1	62	6.316990667155724E-4	7.266760431317394E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	0	5	1	0	23	34	-1	35	47														CASSLAGGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCTCTCCGGGTCTATGAACACTGAAGCTTTCTTTGGACAA	CASSSLSGSMNTEAFF	In	VDJ	1	64	6.520764559644618E-4	7.501172058134083E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	4	0	7	4	23	36	47	43	51						01,02								CASSSLSGSMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGGACTAAAGAGGACAATGAGCAGTTCTTCGGGCCA	CAISRTKEDNEQFF	In	VDJ	1	66	6.724538452133513E-4	7.735583684950774E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	9	5	2	6	23	34	42	36	48						01,02								CAISRTKEDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGACAGGGCTAACCAACTATGGCTACACCTTCGGTTCG	CASSGGTGLTNYGYTF	In	VDJ	1	67	6.82642539837796E-4	7.852789498359119E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	2	3	6	23	35	47	38	53														CASSGGTGLTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGCACTAGCGGGAAACCGAAATGAGCAGTTCTTCGGGCCA	CAIALAGNRNEQFF	In	VDJ	1	67	6.82642539837796E-4	7.852789498359119E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	3	3	7	4	6	23	30	44	34	50														CAIALAGNRNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATAAAACATACAGGGAATAGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	70	7.132086237111302E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	3	6	9	5	23	33	48	42	53														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGGTCAGGGCGTTCATAAGGCTACACCTTCGGTTCG		Out	VDJ	1	73	7.437747075844643E-4		47	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	4	3	8	6	9	23	38	49	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGGGACAGGGGAGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	76	7.743407914577984E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	2	3	3	2	23	35	48	38	50														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATGGCTAGCGGGAGTGAAAGCACAGATACGCAGTATTTTGGCCCA	CASSYMASGSESTDTQYF	In	VDJ	1	83	8.456616538289114E-4	9.72808251289264E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	2	0	4	4	23	38	52	42	56														CASSYMASGSESTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAGGACAGGGTTAAGTCAGCCCCAGCATTTTGGTGAT	CASSSRTGLSQPQHF	In	VDJ	1	83	8.456616538289114E-4	9.72808251289264E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	6	3	5	23	36	47	39	52														CASSSRTGLSQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTTTCGCCCGGTGAGCAGTTCTTCGGGCCA	CASRLSPGEQFF	In	VDJ	2	105	0.0010698129355666951	0.0012306610407876231	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	10	9	0	9	23	-1	37	34	46						01,02								CASRLSPGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACATTCGGGACAGCTCCGCAAGAGACCCAGTACTTCGGGCCA	CASSTFGTAPQETQYF	In	VDJ	2	105	0.0010698129355666951	0.0012306610407876231	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	2	7	5	23	34	48	41	53														CASSTFGTAPQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAACCCAGGGCACACCGGGGAGCTGTTTTTTGGAGAA	CASSYNPGHTGELFF	In	VDJ	2	111	0.0011309451033133635	0.00130098452883263	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	3	4	1	23	38	47	42	48														CASSYNPGHTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCTAATAGCGGCGGGATATGGTACGAGCAGTACTTCGGGCCG	CASSANSGGIWYEQYF	In	VDJ	2	112	0.0011411337979378082	0.0013127051101734647	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	5	4	6	10	23	34	46	40	56						01,02								CASSANSGGIWYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCCCCTAACAGATACGCAGTATTTTGGCCCA	CASSYGPLTDTQYF	In	VDJ	2	121	0.0012328320495578107	0.001418190342240975	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	8	0	3	0	5	23	-1	42	38	47														CASSYGPLTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGCCCCTTTAGCGGGAGACCGCACAGATACGCAGTATTTTGGCCCA	CASSPAPLAGDRTDTQYF	In	VDJ	2	126	0.0012837755226800343	0.0014767932489451476	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	2	1	11	3	23	34	54	45	57														CASSPAPLAGDRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCAAGGGACTAGCGGGAGTAGGTGAGCAGTTCTTCGGGCCA	CASSGKGLAGVGEQFF	In	VDJ	2	126	0.0012837755226800343	0.0014767932489451476	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	9	5	4	23	35	54	40	58														CASSGKGLAGVGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTTCGCTCGACAGCGCCATTTGAAGCTTTCTTTGGACAA	CASVRSTAPFEAFF	In	VDJ	2	137	0.0013958511635489262	0.0016057196436943273	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	5	7	8	7	23	32	45	40	52														CASVRSTAPFEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACAGGCACTGCCTACGAGCAGTACTTCGGGCCG	CASSYTGTAYEQYF	In	VDJ	2	140	0.0014264172474222603	0.0016408813877168307	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	4	2	1	5	23	37	43	38	48														CASSYTGTAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGCCCGGGAGCGGGACTGGCGAGCAGTACTTCGGGCCG	CASSYPPGSGTGEQYF	In	VDJ	3	165	0.0016811346130333781	0.0019338959212376935	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	3	6	9	4	23	38	54	47	58														CASSYPPGSGTGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCACCCTGGGACGAACACTGAAGCTTTCTTTGGACAA	CASHPGTNTEAFF	In	VDJ	3	166	0.0016913233076578228	0.001945616502578528	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	0	7	1	6	0	23	32	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHPGTNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACAGCTGAACACTGAAGCTTTCTTTGGACAA	CASSYGQLNTEAFF	In	VDJ	4	242	0.0024656640991156213	0.00283638068448195	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	0	0	1	23	-1	44	38	45														CASSYGQLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTGGAGGGCGGCTAGCGGAAGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYWRAASGRSSYNEQFF	In	VDJ	5	315	0.0032094388067000854	0.003691983122362869	60	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	0	11	6	21	35	53	46	59						01,02								CASSYWRAASGRSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGATTACAGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGLQGYSNQPQHF	In	VDJ	5	328	0.0033418918368178668	0.0038443506797937177	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	0	5	2	23	35	47	40	49														CASSGLQGYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCGCTGGGCGGGAGGGGTCAAGAGACCCAGTACTTCGGGCCA	CAISPLGGRGQETQYF	In	VDJ	6	369	0.0037596283164201003	0.004324894514767932	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	0	2	7	2	23	35	51	42	53														CAISPLGGRGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGGCGAAGCGTACTGAGCAGTTCTTCGGGCCA	CASSYSGQAKRTEQFF	In	VDJ	7	430	0.004381138688511228	0.005039849976558837	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	4	9	0	10	23	-1	48	40	58														CASSYSGQAKRTEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCTGGGGACAGCCTTTTATCAGCCCCAGCATTTTGGTGAT	CASSYSLGTAFYQPQHF	In	VDJ	10	674	0.0068671801768757385	0.007899671823722457	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	5	5	4	6	23	40	51	44	57														CASSYSLGTAFYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGTGACTAGCGGGAGGCACCAGTTCTTCGGGCCA	CASSPPVTSGRHQFF	In	VDJ	1	19	1.935851978644496E-4	2.226910454758556E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	1	13	3	3	24	41	57	44	60													Vb 18	CASSPPVTSGRHQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGACTTGGCAGGGGGCAATGGCTACACCTTCGGTTCG	CASSPDLAGGNGYTF	In	VDJ	1	24	2.4452867098667317E-4	2.8129395218002813E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	6	11	1	24	35	54	46	55													Vb 18	CASSPDLAGGNGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGAGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGRGSYNEQFF	In	VDJ	1	26	2.649060602355626E-4	3.0473511486169713E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	0	0	1	1	24	38	46	39	47													Vb 18	CASSPGRGSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPPAGANVLTF	In	VDJ	1	27	2.750947548600073E-4	3.1645569620253165E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	5	2	2	0	24	38	-1	40	43													Vb 18	CASSPPAGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAGGGGGTTCGATGGGGCCACGAGTCAGCCCCAGCATTTTGGTGAT	CASSPRGFDGATSQPQHF	In	VDJ	1	28	2.8528344948445205E-4	3.281762775433662E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	1	6	1	17	24	38	45	39	62													Vb 18	CASSPRGFDGATSQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGGCCGCGCCTATGGCTACACCTTCGGTTCG	CASSPGGRAYGYTF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	6	0	4	0	5	24	-1	45	39	50													Vb 18	CASSPGGRAYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGAGACCAAATGAAAAACTGTTTTTTGGCAGT	CASSGRPNEKLFF	In	VDJ	1	29	2.9547214410889676E-4	3.3989685888420064E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	2	5	0	4	24	-1	41	36	45													Vb 18	CASSGRPNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTCGGCGGGACAGTTAATGAAAAACTGTTTTTTGGCAGT	CASSFGGTVNEKLFF	In	VDJ	1	33	3.3622692260667564E-4	3.867791842475387E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	4	6	1	24	36	49	42	50													Vb 18	CASSFGGTVNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTTCAAGCAGCGTGGGGTAATGAGCAGTTCTTCGGGCCA	CASSPLQAAWGNEQFF	In	VDJ	1	34	3.4641561723112036E-4	3.984997655883732E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	6	2	7	14	1	24	38	56	52	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLQAAWGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACCAAAGGGAAAAACTGTTTTTTGGCAGT	CASSPDQREKLFF	In	VDJ	1	35	3.566043118555651E-4	4.102203469292077E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	3	1	7	8	0	6	24	-1	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDQREKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGACTAGCGACGAGCAGTACTTCGGGCCG	CASSPPTSDEQYF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	6	5	0	0	24	-1	-1	41	49						01,02							Vb 18	CASSPPTSDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACTCCCGGACAGGGGGCTGCTTACTTCGGGCCA	CASSPTPGQGAAYF	In	VDJ	1	41	4.1773647960223335E-4	4.805438349742147E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	0	14	7	4	24	38	56	45	60													Vb 18	CASSPTPGQGAAYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGTGGAAGAGACCCAGTACTTCGGGCCA	CASSPPVEETQYF	In	VDJ	1	45	4.584912581000122E-4	5.274261603375527E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	0	0	10	3	0	3	24	-1	43	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPVEETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCATTTCAGCGGGAGGGCCTGCACATTCAGTACTTCGGCGCC		Out	VDJ	1	56	5.705668989689041E-4		52	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	6	0	8	6	5	24	41	57	47	62													Vb 18	X+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-04*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCAGACTAGCGGCGAGCACAGATACGCAGTATTTTGGCCCA	CASSPLRLAASTDTQYF	In	VDJ	1	56	5.705668989689041E-4	6.563525550867324E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	5	0	3	2	24	40	52	43	54						01,02							Vb 18	CASSPLRLAASTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGACAGGGTGCAGACCCAGTACTTCGGGCCA	CASSPGDRVQTQYF	In	VDJ	1	59	6.011329828422382E-4	6.915142991092358E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	3	6	1	3	24	39	49	40	52													Vb 18	CASSPGDRVQTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
TGTGCCAGCTCACCAACGCGGGGGGCTAAAACCGACAGGGCCGTTCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTRGAKTDRAVRSYNEQFF	In	VDJ	1	59	6.011329828422382E-4	6.915142991092358E-4	69	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	1	0	2	22	0	15	25	17	47													Vb 18	CASSPTRGAKTDRAVRSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
GTGCCAGCTCACCTTGCCCCGAGGGTATCGGACCCGGCCATATATAGGGTAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	62	6.316990667155724E-4		71	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	0	2	7	27	-1	13	25	20	52													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGTCCACAGGGAGGAAGGCTACGAGCAGTACTTCGGGCCG	CASSVHREEGYEQYF	In	VDJ	1	64	6.520764559644618E-4	7.501172058134083E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	6	3	3	3	5	7	24	35	46	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSVHREEGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGGACTATTAATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGTINGANVLTF	In	VDJ	1	71	7.233973183355749E-4	8.321612751992499E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	0	9	3	2	4	24	37	46	39	50						01,02							Vb 18	CASSLGTINGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01	TCRBJ02-06*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGAACAGTCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPREQSSNQPQHF	In	VDJ	2	112	0.0011411337979378082	0.0013127051101734647	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	0	8	1	1	7	24	39	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPREQSSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGACCCTGGGGGGAACAGTCACAGATACGCAGTATTTTGGCCCA	CASSLTLGGTVTDTQYF	In	VDJ	2	137	0.0013958511635489262	0.0016057196436943273	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	1	2	7	6	24	37	50	44	56													Vb 18	CASSLTLGGTVTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCTAGCTACGACAGGACGAACACTGAAGCTTTCTTTGGACAA	CASSSSYDRTNTEAFF	In	VDJ	2	160	0.0016301911399111545	0.001875293014533521	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	1	10	2	24	35	51	45	53													Vb 18	CASSSSYDRTNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGATCACGGGACCCGACAATGAGCAGTTCTTCGGGCCA	CASSPPITGPDNEQFF	In	VDJ	3	191	0.0019460406732689408	0.0022386310360993904	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	0	0	7	5	6	3	24	41	52	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPITGPDNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACATCCTCTAGGGAAGGGGACTGAAGCTTTCTTTGGACAA	CASSPHPLGKGTEAFF	In	VDJ	3	211	0.002149814565757835	0.0024730426629160805	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	5	12	0	24	40	-1	52	57													Vb 18	CASSPHPLGKGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTGGGTCACCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGSPANTGELFF	In	VDJ	4	247	0.002516607572237845	0.002894983591186123	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	4	0	9	0	2	7	24	37	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLGSPANTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGCGGGACAGGCGGAAACACCATATATTTTGGAGAG	CASSPGGTGGNTIYF	In	VDJ	4	251	0.002557362350735624	0.002941865916549461	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	4	4	3	1	24	39	50	42	51													Vb 18	CASSPGGTGGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTGGGGACAGTTGAACACTGAAGCTTTCTTTGGACAA	CASSPWGQLNTEAFF	In	VDJ	4	257	0.002618494518482292	0.003012189404594468	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	0	3	1	24	38	48	41	49													Vb 18	CASSPWGQLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGCAGGGAAGACTATGGCTACACCTTCGGTTCG	CASSPRREDYGYTF	In	VDJ	5	300	0.0030566083873334146	0.0035161744022503515	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	3	3	3	24	38	46	41	49													Vb 18	CASSPRREDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGGACAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSGQGNQPQHF	In	VDJ	6	401	0.004085666544402331	0.004699953117674636	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	2	0	0	24	-1	-1	35	43													Vb 18	CASSGQGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGAGGGGAGTAGGTCAGCCCCAGCATTTTGGTGAT	CASSPGRGVGQPQHF	In	VDJ	11	700	0.007132086237111301	0.008204406938584154	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	0	6	0	7	24	-1	46	38	53													Vb 18	CASSPGRGVGQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCAGGGGAAGGTATTGCCGGGGAGCTGTTTTTTGGAGAA	CASSPGEGIAGELFF	In	VDJ	25	1633	0.016638138321718222	0.019139709329582748	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	2	0	8	6	1	8	24	39	44	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGEGIAGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	4240B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				1692	1470	157	63	0	708	592	110	6	0	98148	85320	9156	3672	0	0.165947691	7.6811657	0.159592628	7.95664549				12740	0.114375681	0.0598921701	0.0520642288	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:48	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8687943025609102	MSKCC- Snyder- P01-01		1457.0	
